{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:05:45Z","timestamp":1793379945882,"version":"4.5.0"},"reference-count":427,"publisher":"American Chemical Society (ACS)","issue":"34","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100018536","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2026ZD01909000"],"award-info":[{"award-number":["2026ZD01909000"]}],"id":[{"id":"10.13039\/501100018536","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2023YFC3403303"],"award-info":[{"award-number":["2023YFC3403303"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2023YFC3403304"],"award-info":[{"award-number":["2023YFC3403304"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471551"],"award-info":[{"award-number":["32471551"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401342"],"award-info":[{"award-number":["82401342"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>RNA vaccines have become a transformative technology in infectious disease prevention and cancer treatment, thanks to their rapid development, high immunogenicity, and scalability in production. However, the clinical application of RNA vaccines faces significant challenges, including the inherent instability and susceptibility to degradation of naked RNA, its poor permeability across cell membranes, and the potential for nonspecific immune responses following systemic administration. Nanodelivery systems are key to addressing these challenges; by providing physical protection, enabling targeted delivery, promoting cellular uptake, and facilitating escape from endosomes, they significantly enhance the efficacy and safety of RNA vaccines. This review provides a comprehensive overview of the latest advances in nanodelivery systems for RNA vaccines, focusing on the characteristics of three distinct types of RNA vaccines\u2500linear mRNA, self-amplifying RNA, and circular RNA\u2500as well as the applications of lipid nanoparticles, polymeric nanoparticles, virus-like particles, and other emerging nanocarriers in enhancing RNA stability, boosting immunogenicity, and enabling precise targeting. Furthermore, this study will examine the key challenges in this field, including vector biosafety, large-scale production, cost-effectiveness, and storage and transportation, and will also outline future research directions and prospects for clinical translation.<\/jats:p>","DOI":"10.1021\/acsnano.6c10327","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:01:11Z","timestamp":1786734071000},"page":"23649-23695","source":"Crossref","is-referenced-by-count":1,"title":["Advances\nand Challenges\nin Nanodelivery Systems for\nRNA Vaccines"],"prefix":"10.1021","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3651-6076","authenticated-orcid":true,"given":"Hang","family":"Li","sequence":"first","affiliation":[{"name":"Sichuan University , , , ,","place":["Chengdu, Sichuan, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Yang","sequence":"additional","affiliation":[{"name":"Sichuan University , , , ,","place":["Chengdu, Sichuan, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiao","family":"Guo","sequence":"additional","affiliation":[{"name":"Sichuan University , , , ,","place":["Chengdu, Sichuan, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Cai","sequence":"additional","affiliation":[{"name":"Sichuan University , , , ,","place":["Chengdu, Sichuan, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3392-5443","authenticated-orcid":true,"given":"Aiping","family":"Tong","sequence":"additional","affiliation":[{"name":"Sichuan University , , , ,","place":["Chengdu, Sichuan, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"7","key":"2026090306593993700_cit1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41419-022-05075-2","article-title":"RNA-based therapeutics: an overview\nand prospectus","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"6","key":"2026090306593993700_cit2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical\nprogress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"2026090306593993700_cit3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based\nCOVID-19 vaccine boosters induce\nneutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"issue":"3","key":"2026090306593993700_cit4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-024-01091-9","article-title":"Vax-Innate: improving\ntherapeutic cancer vaccines by modulating T cells and the tumour microenvironment","volume":"25","author":"Baharom","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"2026090306593993700_cit5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-Amplifying\nRNA Vaccines Give Equivalent Protection against Influenza to mRNA\nVaccines but at Much Lower Doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"issue":"1","key":"2026090306593993700_cit6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13045-025-01694-2","article-title":"Replicon RNA\nvaccines: design, delivery, and immunogenicity in infectious diseases\nand cancer","volume":"18","author":"Tang","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"7995","key":"2026090306593993700_cit7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","article-title":"Tumour circular\nRNAs elicit anti-tumour immunity by\nencoding cryptic peptides","volume":"625","author":"Huang","year":"2024","journal-title":"Nature"},{"issue":"1","key":"2026090306593993700_cit8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12951-025-03800-5","article-title":"mRNA vaccines: immunogenicity\nand quality characteristics","volume":"24","author":"Quan","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"2026090306593993700_cit9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics \u2013\ndeveloping a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug\nDiscovery"},{"issue":"17","key":"2026090306593993700_cit10","doi-asserted-by":"publisher","first-page":"16204","DOI":"10.1021\/acsnano.4c15765","article-title":"Cancer Nanovaccines: Mechanisms, Design Principles,\nand Clinical Translation","volume":"19","author":"Zaccariotto","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"2026090306593993700_cit11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","article-title":"A long-term study of AAV gene therapy\nin dogs with hemophilia A identifies clonal expansions of transduced\nliver cells","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"2026090306593993700_cit12","first-page":"553","article-title":"Nuclease-Mediated\nGene Therapies for Inherited Metabolic Diseases of the Liver","volume":"90","author":"Bryson","year":"2017","journal-title":"Yale J. Biol. Med."},{"issue":"5","key":"2026090306593993700_cit13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety\nof the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl.\nJ. Med."},{"issue":"27","key":"2026090306593993700_cit14","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy\nof the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl.\nJ. Med."},{"issue":"1","key":"2026090306593993700_cit15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran,\nan RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"2026090306593993700_cit16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201901989","article-title":"Integrating\nArtificial Intelligence and Nanotechnology for Precision Cancer Medicine","volume":"32","author":"Adir","year":"2020","journal-title":"Adv. Mater."},{"issue":"1","key":"2026090306593993700_cit17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nat. Rev. Methods\nPrimers"},{"issue":"4","key":"2026090306593993700_cit18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce\nthe risks of mRNA drug and vaccine toxicity","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026090306593993700_cit19","doi-asserted-by":"publisher","first-page":"115175","DOI":"10.1016\/j.addr.2023.115175","article-title":"The immunostimulatory\nnature of mRNA lipid nanoparticles","volume":"205","author":"Sharma","year":"2024","journal-title":"Adv. Drug\nDelivery Rev."},{"issue":"2","key":"2026090306593993700_cit20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41551-024-01208-4","article-title":"Dendritic-cell-targeting virus-like\nparticles as potent mRNA vaccine\ncarriers","volume":"9","author":"Yin","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"2026090306593993700_cit21","doi-asserted-by":"publisher","first-page":"217752","DOI":"10.1016\/j.canlet.2025.217752","article-title":"Cancer mRNA vaccines:\nclinical application progress and challenges","volume":"625","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"key":"2026090306593993700_cit22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2020_230","article-title":"mRNA-Based Vaccines and Mode of Action","volume":"440","author":"Gergen","year":"2020","journal-title":"Curr. Topics Microbiol. Immunol."},{"issue":"7","key":"2026090306593993700_cit23","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.apsb.2022.03.011","article-title":"mRNA cancer vaccines:\nAdvances, trends and challenges","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharm.\nSin. B"},{"issue":"6292","key":"2026090306593993700_cit24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1126\/science.aad9868","article-title":"Translational\ncontrol by 5\u2032-untranslated\nregions of eukaryotic mRNAs","volume":"352","author":"Hinnebusch","year":"2016","journal-title":"Science"},{"issue":"6","key":"2026090306593993700_cit25","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1073\/pnas.94.6.2410","article-title":"Four highly stable eukaryotic mRNAs assemble 3\u2032\nuntranslated region RNA\u2013protein complexes sharing cis and trans\ncomponents","volume":"94","author":"Holcik","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"40","key":"2026090306593993700_cit26","doi-asserted-by":"publisher","first-page":"2004452","DOI":"10.1002\/adma.202004452","article-title":"Leveraging mRNA Sequences and Nanoparticles to Deliver\nSARS-CoV-2 Antigens In Vivo","volume":"32","author":"Zeng","year":"2020","journal-title":"Adv. Mater."},{"issue":"2","key":"2026090306593993700_cit27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41587-024-02174-7","article-title":"Branched chemically modified poly(A)\ntails enhance the translation capacity of mRNA","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"2026090306593993700_cit28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","article-title":"Tailoring mRNA Vaccine\nto Balance Innate\/Adaptive Immune Response","volume":"26","author":"Linares-Ferna\u0301ndez","year":"2020","journal-title":"Trends Mol. Med."},{"issue":"4","key":"2026090306593993700_cit29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"D., mRNA vaccines \u2013 a new\nera in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"7525","key":"2026090306593993700_cit30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nature13802","article-title":"Pseudouridine profiling reveals regulated mRNA pseudouridylation\nin yeast and human cells","volume":"515","author":"Carlile","year":"2014","journal-title":"Nature"},{"issue":"9","key":"2026090306593993700_cit31","doi-asserted-by":"publisher","first-page":"111300","DOI":"10.1016\/j.celrep.2022.111300","article-title":"N1-methylpseudouridine found within\nCOVID-19 mRNA vaccines produces faithful protein products","volume":"40","author":"Kim","year":"2022","journal-title":"Cell Rep."},{"issue":"2","key":"2026090306593993700_cit32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression\nof RNA\nRecognition by Toll-like Receptors: The Impact of Nucleoside Modification\nand the Evolutionary Origin of RNA","volume":"23","author":"Kariko\u0301","year":"2005","journal-title":"Immunity"},{"key":"2026090306593993700_cit33","doi-asserted-by":"publisher","first-page":"901510","DOI":"10.3389\/fcell.2022.901510","article-title":"The Pivotal\nRole of Chemical Modifications in mRNA Therapeutics","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"2026090306593993700_cit34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s12276-023-00999-x","article-title":"Knife\u2019s edge:\nBalancing immunogenicity and reactogenicity in mRNA vaccines","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"2026090306593993700_cit35","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into\nmRNA yields superior nonimmunogenic vector with increased translational\ncapacity and biological stability","volume":"16","author":"Kariko\u0301","year":"2008","journal-title":"Mol. Ther."},{"issue":"26","key":"2026090306593993700_cit36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz6893","article-title":"Impact of mRNA chemistry and manufacturing process\non innate immune activation","volume":"6","author":"Nelson","year":"2020","journal-title":"Sci. Adv."},{"issue":"21","key":"2026090306593993700_cit37","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal\nmRNA for therapy: HPLC purification eliminates immune activation and\nimproves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Kariko\u0301","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"2026090306593993700_cit38","doi-asserted-by":"publisher","first-page":"102179","DOI":"10.1016\/j.omtn.2024.102179","article-title":"Identification of film-based formulations\nthat move mRNA lipid nanoparticles out of the freezer","volume":"35","author":"Doan","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"11","key":"2026090306593993700_cit39","doi-asserted-by":"publisher","first-page":"103341","DOI":"10.1016\/j.drudis.2022.103341","article-title":"Self-amplifying mRNA\nvaccines: Mode of action, design, development and optimization","volume":"27","author":"Pourseif","year":"2022","journal-title":"Drug Discovery Today"},{"issue":"5","key":"2026090306593993700_cit40","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.ymthe.2022.01.001","article-title":"A self-amplifying mRNA\nSARS-CoV-2 vaccine candidate induces safe and robust protective immunity\nin preclinical models","volume":"30","author":"Maruggi","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"2026090306593993700_cit41","doi-asserted-by":"publisher","first-page":"6932","DOI":"10.1038\/s41598-019-43422-0","article-title":"In vitro evolution\nof enhanced RNA replicons for immunotherapy","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"issue":"25","key":"2026090306593993700_cit42","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1056\/NEJMcibr2009737","article-title":"Amplifying RNA Vaccine\nDevelopment","volume":"382","author":"Fuller","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"2026090306593993700_cit43","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.3390\/ijms21145130","article-title":"Self-Amplifying\nRNA Viruses as RNA Vaccines","volume":"21","author":"Lundstrom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"2026090306593993700_cit44","doi-asserted-by":"publisher","first-page":"11371","DOI":"10.1073\/pnas.93.21.11371","article-title":"Alphavirus-based expression vectors:\nstrategies and applications","volume":"93","author":"Frolov","year":"1996","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"issue":"8","key":"2026090306593993700_cit45","doi-asserted-by":"publisher","first-page":"101134","DOI":"10.1016\/j.xcrm.2023.101134","article-title":"Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine\nexpressing an anchored RBD: A randomized, observer-blind phase 1 study","volume":"4","author":"Akahata","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"1","key":"2026090306593993700_cit46","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA\nSARS-CoV-2 lipid nanoparticle vaccine candidate\ninduces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"2026090306593993700_cit47","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41570-025-00763-x","article-title":"The impact\nof chemical reactivity\non the quality and stability of RNA-LNP pharmaceuticals","volume":"9","author":"Kovac\u030cic\u030c","year":"2025","journal-title":"Nat. Rev. Chem."},{"issue":"10","key":"2026090306593993700_cit48","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70414","article-title":"Design Strategies\nfor Novel Lipid\nNanoparticle for mRNA Vaccine and Therapeutics: Current Understandings\nand Future Perspectives","volume":"6","author":"Li","year":"2025","journal-title":"MedComm"},{"issue":"8","key":"2026090306593993700_cit49","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.ymthe.2023.06.017","article-title":"A localizing nanocarrier\nformulation enables multi-target immune responses to multivalent replicating\nRNA with limited systemic inflammation","volume":"31","author":"Kimura","year":"2023","journal-title":"Mol.\nTher."},{"issue":"12","key":"2026090306593993700_cit50","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3390\/ph16121634","article-title":"RNA Combined\nwith Nanoformulation to Advance Therapeutic Technologies","volume":"16","author":"Lima","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"4","key":"2026090306593993700_cit51","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","article-title":"The therapeutic\npotential of circular RNAs","volume":"26","author":"O\u2019Leary","year":"2025","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"2026090306593993700_cit52","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.celrep.2016.03.058","article-title":"The Biogenesis of Nascent Circular\nRNAs","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep."},{"issue":"12","key":"2026090306593993700_cit53","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1016\/j.celrep.2019.02.078","article-title":"Expanded Expression\nLandscape and Prioritization of Circular RNAs\nin Mammals","volume":"26","author":"Ji","year":"2019","journal-title":"Cell Rep."},{"issue":"7441","key":"2026090306593993700_cit54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs\nare a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"issue":"7441","key":"2026090306593993700_cit55","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA\ncircles function as efficient\nmicroRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"issue":"4","key":"2026090306593993700_cit56","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s44222-024-00259-1","article-title":"Engineering circular RNA medicines","volume":"3","author":"Cao","year":"2025","journal-title":"Nat. Rev.\nBioeng."},{"issue":"1","key":"2026090306593993700_cit57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12943-023-01719-9","article-title":"A novel\npolypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via\ndegradation of mTOR","volume":"22","author":"Song","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"2026090306593993700_cit58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting\nMitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS\nOutput","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"issue":"1","key":"2026090306593993700_cit59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-022-01521-z","article-title":"METTL14-mediated m(6)A\nmodification\nof circORC5 suppresses gastric cancer progression by regulating miR-30c-2\u20133p\/AKT1S1\naxis","volume":"21","author":"Fan","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"2026090306593993700_cit60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-021-01482-9","article-title":"CircNFIB\ninhibits tumor growth and metastasis through suppressing MEK1\/ERK\nsignaling in intrahepatic cholangiocarcinoma","volume":"21","author":"Du","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"2026090306593993700_cit61","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1038\/s41467-022-31327-y","article-title":"Pervasive translation\nof circular RNAs driven by short IRES-like elements","volume":"13","author":"Fan","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"2026090306593993700_cit62","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1252","article-title":"Synthetic\ncircular RNA switches and\ncircuits that control protein expression in mammalian cells","volume":"51","author":"Kameda","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2026090306593993700_cit63","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1038\/s41467-023-43065-w","article-title":"Rational design\nof microRNA-responsive switch for programmable translational control\nin mammalian cells","volume":"14","author":"Ning","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"2026090306593993700_cit64","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/cr.2017.31","article-title":"Extensive\ntranslation of circular\nRNAs driven by N(6)-methyladenosine","volume":"27","author":"Yang","year":"2017","journal-title":"Cell Res."},{"issue":"1","key":"2026090306593993700_cit65","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","article-title":"N6-Methyladenosine Modification Controls Circular\nRNA Immunity","volume":"76","author":"Chen","year":"2019","journal-title":"Mol. Cell"},{"issue":"18","key":"2026090306593993700_cit66","doi-asserted-by":"publisher","first-page":"10368","DOI":"10.1093\/nar\/gkaa704","article-title":"Comprehensive analysis\nof translation from overexpressed circular RNAs reveals pervasive\ntranslation from linear transcripts","volume":"48","author":"Ho-Xuan","year":"2020","journal-title":"Nucleic\nAcids Res."},{"issue":"10","key":"2026090306593993700_cit67","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","article-title":"Circular\nRNA vaccines against SARS-CoV-2 and emerging variants","volume":"185","author":"Qu","year":"2022","journal-title":"Cell"},{"key":"2026090306593993700_cit68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymeth.2021.02.020","article-title":"The design\nand synthesis of circular RNAs","volume":"196","author":"Obi","year":"2021","journal-title":"Methods"},{"issue":"11","key":"2026090306593993700_cit69","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.7150\/thno.33921","article-title":"Advances in intracellular\ndelivery through supramolecular self-assembly of oligonucleotides\nand peptides","volume":"9","author":"Kim","year":"2019","journal-title":"Theranostics"},{"issue":"17","key":"2026090306593993700_cit70","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers\u2019\nentry into the cell: relevance\nto drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"2026090306593993700_cit71","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis\nof lipid nanoparticle-mediated siRNA delivery, intracellular trafficking\nand endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"2026090306593993700_cit72","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","article-title":"Challenges\nand Recent Progress in Oral Drug Delivery\nSystems for Biopharmaceuticals","volume":"11","author":"Homayun","year":"2019","journal-title":"Pharmaceutics"},{"issue":"5","key":"2026090306593993700_cit73","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.xphs.2018.01.007","article-title":"Challenges\nand Opportunities for the Subcutaneous Delivery\nof Therapeutic Proteins","volume":"107","author":"Turner","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"19","key":"2026090306593993700_cit74","doi-asserted-by":"publisher","first-page":"11038","DOI":"10.1093\/nar\/gkab884","article-title":"Multifaceted\nimpact of a nucleoside monophosphate kinase\non 5\u2032-end-dependent mRNA degradation in bacteria","volume":"49","author":"Hui","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2026090306593993700_cit75","doi-asserted-by":"publisher","first-page":"1287940","DOI":"10.3389\/fimmu.2024.1287940","article-title":"Innate immune responses\nto RNA: sensing and signaling","volume":"15","author":"Luan","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"2026090306593993700_cit76","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/vaccines13010068","article-title":"Development\nand Evaluation of the Immunogenic Potential of an Unmodified Nucleoside\nmRNA Vaccine for Herpes Zoster","volume":"13","author":"Zhang","year":"2025","journal-title":"Vaccines"},{"issue":"1","key":"2026090306593993700_cit77","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear\nphagocyte\nsystem blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"2026090306593993700_cit78","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical\ninteractions at the\nnano-bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat. Mater."},{"issue":"11","key":"2026090306593993700_cit79","doi-asserted-by":"publisher","first-page":"13015","DOI":"10.1021\/acsnano.9b05679","article-title":"Overcoming the Reticuloendothelial\nSystem Barrier to\nDrug Delivery with a \u201cDon\u2019t-Eat-Us\u201d Strategy","volume":"13","author":"Tang","year":"2019","journal-title":"ACS Nano"},{"issue":"1","key":"2026090306593993700_cit80","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70035","article-title":"Nonviral targeted mRNA delivery: principles,\nprogresses, and challenges","volume":"6","author":"He","year":"2025","journal-title":"MedComm"},{"key":"2026090306593993700_cit81","doi-asserted-by":"publisher","first-page":"103398","DOI":"10.1016\/j.mattod.2026.103398","article-title":"The endosomal escape problem solved?\nNew insights into lipid nanoparticle delivery efficiency","volume":"98","author":"Rachamala","year":"2026","journal-title":"Mater. Today"},{"issue":"7929","key":"2026090306593993700_cit82","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41586-022-05221-y","article-title":"CLN3 is required\nfor the clearance of glycerophosphodiesters from lysosomes","volume":"609","author":"Laqtom","year":"2022","journal-title":"Nature"},{"issue":"47","key":"2026090306593993700_cit83","doi-asserted-by":"publisher","first-page":"40293","DOI":"10.1021\/acsnano.5c11721","article-title":"Endosomal\nEscape of Lipid Nanoparticles: A Perspective on the Literature Data","volume":"19","author":"Pei","year":"2025","journal-title":"ACS Nano"},{"issue":"16","key":"2026090306593993700_cit84","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide\ntransfer into cells in culture and in vivo: polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"2026090306593993700_cit85","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis\nof nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Controlled Release"},{"issue":"5","key":"2026090306593993700_cit86","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing\nionizable\nphospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas\ngene editing","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"issue":"1","key":"2026090306593993700_cit87","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/s41467-024-45666-5","article-title":"Liquid crystalline\ninverted lipid phases encapsulating\nsiRNA enhance lipid nanoparticle mediated transfection","volume":"15","author":"Pattipeiluhu","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"2026090306593993700_cit88","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational\ndesign of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"2026090306593993700_cit89","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief update\non endocytosis of nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Adv. Drug Delivery\nRev."},{"issue":"1","key":"2026090306593993700_cit90","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/molecules26010036","article-title":"Photoinduced Endosomal Escape Mechanism:\nA View from Photochemical Internalization Mediated by CPP-Photosensitizer\nConjugates","volume":"26","author":"Soe","year":"2020","journal-title":"Molecules"},{"key":"2026090306593993700_cit91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41587-026-03022-6","article-title":"In vivo endosomal escape\nassay identifies mechanisms for efficient hepatic LNP delivery","author":"Jozic\u0301","year":"2026","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"2026090306593993700_cit92","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle\nSystems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"issue":"4","key":"2026090306593993700_cit93","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4161\/rna.8.4.15394","article-title":"Protein expression\nfrom exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking\nvia the lysosomal pathway","volume":"8","author":"Lorenz","year":"2011","journal-title":"RNA Biol."},{"issue":"7","key":"2026090306593993700_cit94","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/gt.2011.17","article-title":"Selective uptake of\nnaked vaccine RNA by dendritic cells is driven by macropinocytosis\nand abrogated upon DC maturation","volume":"18","author":"Diken","year":"2011","journal-title":"Gene Ther."},{"issue":"8","key":"2026090306593993700_cit95","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors\nfor gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"23","key":"2026090306593993700_cit96","doi-asserted-by":"publisher","first-page":"13301","DOI":"10.1021\/acs.chemrev.4c00472","article-title":"Technologies\nfor Targeted RNA Degradation and Induced\nRNA Decay","volume":"124","author":"Mikutis","year":"2024","journal-title":"Chem. Rev."},{"issue":"10","key":"2026090306593993700_cit97","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1021\/acs.chemrev.4c00191","article-title":"Correction to Chemically Modified\nPlatforms for Better RNA Therapeutics","volume":"124","author":"Shi","year":"2024","journal-title":"Chem.\nRev."},{"issue":"1","key":"2026090306593993700_cit98","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12951-022-01478-7","article-title":"Recent advances in\nmRNA-LNP therapeutics: immunological and pharmacological aspects","volume":"20","author":"Kiaie","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"2026090306593993700_cit99","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20240044","article-title":"Exploring the Potential\nand Advancements of Circular\nRNA Therapeutics","volume":"5","author":"Wang","year":"2025","journal-title":"Exploration"},{"issue":"6","key":"2026090306593993700_cit100","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s12276-024-01251-w","article-title":"Optimal design of synthetic circular\nRNAs","volume":"56","author":"Choi","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"2026090306593993700_cit101","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s44222-026-00401-1","article-title":"Design\nprinciples of lipid nanoparticles\nfor RNA delivery","volume":"4","author":"Arral","year":"2026","journal-title":"Nat. Rev. Bioeng."},{"issue":"9","key":"2026090306593993700_cit102","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles\nfor nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"2026090306593993700_cit103","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","article-title":"Ionization\nand structural properties of mRNA lipid nanoparticles influence expression\nin intramuscular and intravascular administration","volume":"4","author":"Carrasco","year":"2021","journal-title":"Commun. Biol."},{"issue":"3","key":"2026090306593993700_cit104","doi-asserted-by":"publisher","first-page":"101518","DOI":"10.1016\/j.omtm.2025.101518","article-title":"Rational design\nof lipid nanoparticles\nfor enabling gene therapies","volume":"33","author":"Brimacombe","year":"2025","journal-title":"Mol. Ther. Methods\nClin. Dev."},{"key":"2026090306593993700_cit105","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","article-title":"Lipid nanoparticles\nfor nucleic acid delivery: Current perspectives","volume":"154\u2013155","author":"Samaridou","year":"2020","journal-title":"Adv. Drug Delivery Rev."},{"issue":"9","key":"2026090306593993700_cit106","doi-asserted-by":"publisher","first-page":"1700375","DOI":"10.1002\/smtd.201700375","article-title":"State-of-the-Art Design and Rapid-Mixing\nProduction Techniques of Lipid Nanoparticles for Nucleic Acid Delivery","volume":"2","author":"Evers","year":"2018","journal-title":"Small Methods"},{"issue":"3","key":"2026090306593993700_cit107","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1021\/acsabm.8b00821","article-title":"Antibiotic-Derived\nLipid Nanoparticles to Treat Intracellular Staphylococcus aureus","volume":"2","author":"Zhang","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"2026090306593993700_cit108","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry\nof Lipid Nanoparticles for RNA Delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc.\nChem. Res."},{"issue":"5","key":"2026090306593993700_cit109","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like\nmaterials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"2026090306593993700_cit110","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1002\/anie.202013927","article-title":"A Systematic Study of Unsaturation\nin Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo","volume":"60","author":"Lee","year":"2021","journal-title":"Angew. Chem."},{"key":"2026090306593993700_cit111","doi-asserted-by":"publisher","first-page":"122279","DOI":"10.1016\/j.biomaterials.2023.122279","article-title":"Branched hydrophobic\ntails in lipid\nnanoparticles enhance mRNA delivery for cancer immunotherapy","volume":"301","author":"Yan","year":"2023","journal-title":"Biomaterials"},{"key":"2026090306593993700_cit112","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1038\/ncomms5277","article-title":"Degradable\nlipid nanoparticles with predictable in vivo siRNA delivery activity","volume":"5","author":"Whitehead","year":"2014","journal-title":"Nat. Commun."},{"issue":"8","key":"2026090306593993700_cit113","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective\nmRNA delivery of synthetic lipid nanoparticles for the treatment of\npulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl.\nAcad. Sci. U. S. A."},{"key":"2026090306593993700_cit114","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","article-title":"Lipid nanoparticle technology for\ntherapeutic gene regulation in the liver","volume":"159","author":"Witzigmann","year":"2020","journal-title":"Adv.\nDrug Delivery Rev."},{"key":"2026090306593993700_cit115","doi-asserted-by":"publisher","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid\ncomponents in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Delivery Rev."},{"issue":"3","key":"2026090306593993700_cit116","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","article-title":"Influence of cholesterol\non liposome stability and\non in vitro drug release","volume":"5","author":"Briuglia","year":"2015","journal-title":"Drug Delivery Transl.\nRes."},{"issue":"1","key":"2026090306593993700_cit117","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring\ncholesterol analogues in lipid nanoparticles induce polymorphic shape\nand enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"2026090306593993700_cit118","doi-asserted-by":"publisher","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering\nLipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through\nInhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"issue":"14","key":"2026090306593993700_cit119","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201807748","article-title":"Nanoparticles\nContaining Oxidized\nCholesterol Deliver mRNA to the Liver Microenvironment at Clinically\nRelevant Doses","volume":"31","author":"Paunovska","year":"2019","journal-title":"Adv. Mater."},{"issue":"15","key":"2026090306593993700_cit120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720542115","article-title":"Successful reprogramming of cellular protein production through mRNA\ndelivered by functionalized lipid nanoparticles","volume":"115","author":"Arteta","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"2026090306593993700_cit121","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the\nFormation and Morphology of Lipid Nanoparticles Containing Ionizable\nCationic Lipids and siRNA","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"issue":"8","key":"2026090306593993700_cit122","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1023\/A:1008365716693","article-title":"Pegylated\nliposomal doxorubicin (doxil):\nreduced clinical cardiotoxicity in patients reaching or exceeding\ncumulative doses of 500 mg\/m2","volume":"11","author":"Safra","year":"2000","journal-title":"Ann. Oncol."},{"issue":"1","key":"2026090306593993700_cit123","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1039\/C6NR07353K","article-title":"Effect of partial PEGylation\non particle uptake by macrophages","volume":"9","author":"Sanchez","year":"2017","journal-title":"Nanoscale"},{"key":"2026090306593993700_cit124","doi-asserted-by":"publisher","first-page":"119792","DOI":"10.1016\/j.ijpharm.2020.119792","article-title":"PEG shedding-rate-dependent\nblood clearance of PEGylated\nlipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG\nIgM production","volume":"588","author":"Suzuki","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"15","key":"2026090306593993700_cit125","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/adma.201505822","article-title":"Bioinspired Alkenyl\nAmino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo\nmRNA Delivery","volume":"28","author":"Fenton","year":"2016","journal-title":"Adv. Mater."},{"key":"2026090306593993700_cit126","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle\nsize on the\nin vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"J. Controlled Release"},{"issue":"7","key":"2026090306593993700_cit127","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics\nwith endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"issue":"2","key":"2026090306593993700_cit128","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/pharmaceutics15020597","article-title":"Effect of PEG Anchor\nand Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking\nMethod","volume":"15","author":"Berger","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"2026090306593993700_cit129","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E Binding Drives Structural and Compositional\nRearrangement of mRNA-Containing Lipid Nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"2026090306593993700_cit130","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated\nliposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol.\nAdv. Mater."},{"issue":"11","key":"2026090306593993700_cit131","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine headgroups in ionizable lipids drive immune responses\nto lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"8","key":"2026090306593993700_cit132","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG Antibodies\nBoosted in Humans\nby SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"2026090306593993700_cit133","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bioactmat.2024.03.017","article-title":"Engineering LNPs with polysarcosine lipids for mRNA delivery","volume":"37","author":"Kang","year":"2024","journal-title":"Bioact. Mater."},{"key":"2026090306593993700_cit134","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives\nin lipid nanoparticles facilitates targeted mRNA delivery to the spleen\nand lungs","volume":"345","author":"LoPresti","year":"2022","journal-title":"J. Controlled Release"},{"issue":"4","key":"2026090306593993700_cit135","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ\ntargeting (SORT)\nnanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene\nediting","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"Pt A","key":"2026090306593993700_cit136","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper\nlipids in lipid\nnanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Delivery Rev."},{"key":"2026090306593993700_cit137","doi-asserted-by":"publisher","first-page":"7107","DOI":"10.1038\/srep07107","article-title":"The role\nof the helper lipid on the DNA transfection efficiency of lipopolyplex\nformulations","volume":"4","author":"Du","year":"2014","journal-title":"Sci. Rep."},{"issue":"5373","key":"2026090306593993700_cit138","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.281.5373.78","article-title":"An inverted hexagonal phase of cationic\nliposome-DNA\ncomplexes related to DNA release and delivery","volume":"281","author":"Koltover","year":"1998","journal-title":"Science"},{"issue":"12","key":"2026090306593993700_cit139","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles\nfor mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"11","key":"2026090306593993700_cit140","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization\nof Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with\nFractional Factorial and Definitive Screening Designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"issue":"6","key":"2026090306593993700_cit141","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1021\/acs.nanolett.0c01386","article-title":"Deconvoluting\nLipid Nanoparticle Structure for Messenger RNA Delivery","volume":"20","author":"Eygeris","year":"2020","journal-title":"Nano Lett."},{"issue":"52","key":"2026090306593993700_cit142","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","article-title":"On the\nmechanism\nof tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"44","key":"2026090306593993700_cit143","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202310395","article-title":"Spleen SORT LNP Generated in situ CAR T Cells Extend\nSurvival in a Mouse Model of Lymphoreplete B Cell Lymphoma","volume":"62","author":"A\u0301lvarez-Benedicto","year":"2023","journal-title":"Angew. Chem Int Ed Engl."},{"key":"2026090306593993700_cit144","doi-asserted-by":"publisher","first-page":"103041","DOI":"10.1016\/j.copbio.2023.103041","article-title":"Biological recognition and cellular\ntrafficking of targeted RNA-lipid\nnanoparticles","volume":"85","author":"Escalona-Rayo","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"2026090306593993700_cit145","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2022.11.036","article-title":"siRNA delivery to lymphatic\nendothelial cells via ApoE-mediated uptake by lipid nanoparticles","volume":"353","author":"Sakurai","year":"2023","journal-title":"J. Controlled Release"},{"key":"2026090306593993700_cit146","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jconrel.2023.12.019","article-title":"PEGylated\nnanoparticles interact with macrophages independently of immune response\nfactors and trigger a non-phagocytic, low-inflammatory response","volume":"366","author":"Asoudeh","year":"2024","journal-title":"J. Controlled Release"},{"issue":"4","key":"2026090306593993700_cit147","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/pharmaceutics15041184","article-title":"Key Design Features of Lipid Nanoparticles\nand Electrostatic Charge-Based Lipid Nanoparticle Targeting","volume":"15","author":"Gyanani","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"2026090306593993700_cit148","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active\nand endogenous organ-targeted\nlipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"2026090306593993700_cit149","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jconrel.2023.09.022","article-title":"Control of cell penetration enhancer\nshielding and\nendosomal escape-kinetics crucial for efficient and biocompatible\nsiRNA delivery","volume":"363","author":"Malfanti","year":"2023","journal-title":"J. Controlled Release"},{"issue":"12","key":"2026090306593993700_cit150","doi-asserted-by":"publisher","first-page":"11454","DOI":"10.1021\/acsnano.3c01186","article-title":"Correlating\nthe Structure and Gene Silencing Activity of Oligonucleotide-Loaded\nLipid Nanoparticles Using Small-Angle X-ray Scattering","volume":"17","author":"Hammel","year":"2023","journal-title":"ACS Nano"},{"issue":"3","key":"2026090306593993700_cit151","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/vaccines11030658","article-title":"Recent Advances\nin the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines","volume":"11","author":"Swetha","year":"2023","journal-title":"Vaccines"},{"issue":"8","key":"2026090306593993700_cit152","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles\nfor systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol. Ther."},{"issue":"10","key":"2026090306593993700_cit153","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1016\/S0021-9258(18)61209-8","article-title":"Receptor-mediated in vitro gene transformation\nby a soluble DNA carrier system","volume":"262","author":"Wu","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"3","key":"2026090306593993700_cit154","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/pharmaceutics14030512","article-title":"Nonviral Delivery\nSystems of mRNA Vaccines for Cancer Gene Therapy","volume":"14","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"7","key":"2026090306593993700_cit155","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1039\/C1CS15258K","article-title":"Rational design of\nsmart supramolecular assemblies for gene delivery: chemical challenges\nin the creation of artificial viruses","volume":"41","author":"Miyata","year":"2012","journal-title":"Chem.\nSoc. Rev."},{"issue":"1","key":"2026090306593993700_cit156","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.70002","article-title":"Polymers for mRNA Delivery","volume":"17","author":"Wang","year":"2025","journal-title":"Wiley Interdiscip.\nRev."},{"key":"2026090306593993700_cit157","doi-asserted-by":"publisher","first-page":"121020","DOI":"10.1016\/j.ijpharm.2021.121020","article-title":"mRNA delivery\nvia non-viral carriers for biomedical applications","volume":"607","author":"Shuai","year":"2021","journal-title":"Int. J. Pharm."},{"key":"2026090306593993700_cit158","doi-asserted-by":"publisher","first-page":"115052","DOI":"10.1016\/j.addr.2023.115052","article-title":"A holistic\nanalysis of the intrinsic and delivery-mediated toxicity of siRNA\ntherapeutics","volume":"201","author":"Ranjbar","year":"2023","journal-title":"Adv. Drug Delivery Rev."},{"issue":"49","key":"2026090306593993700_cit159","doi-asserted-by":"publisher","first-page":"20529","DOI":"10.1021\/jacs.1c08484","article-title":"Polymers Strive for\nAccuracy: From\nSequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers\nin Nucleic Acid Therapeutics","volume":"143","author":"Ishaqat","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"2026090306593993700_cit160","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1021\/acscentsci.8b00363","article-title":"Green Tea Catechin\nDramatically Promotes RNAi Mediated by Low-Molecular-Weight Polymers","volume":"4","author":"Shen","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"2026090306593993700_cit161","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2016.02.043","article-title":"Enhanced intranasal\ndelivery of mRNA\nvaccine by overcoming the nasal epithelial barrier via intra- and\nparacellular pathways","volume":"228","author":"Li","year":"2016","journal-title":"J. Controlled Release"},{"issue":"6","key":"2026090306593993700_cit162","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.matt.2022.03.006","article-title":"The roles\nof polymers in mRNA delivery","volume":"5","author":"Huang","year":"2022","journal-title":"Matter"},{"key":"2026090306593993700_cit163","doi-asserted-by":"publisher","first-page":"115302","DOI":"10.1016\/j.addr.2024.115302","article-title":"Navigating\nthe landscape of RNA delivery systems in cardiovascular disease therapeutics","volume":"208","author":"Gil-Cabrerizo","year":"2024","journal-title":"Adv. Drug Delivery Rev."},{"key":"2026090306593993700_cit164","doi-asserted-by":"publisher","first-page":"103296","DOI":"10.1016\/j.bcab.2024.103296","article-title":"Self-assembled PEGylated micelles\nfor precise and targeted drug delivery: Current challenges and future\ndirections","volume":"60","author":"Sinha","year":"2024","journal-title":"Biocatal. Agr. Biotechnol."},{"key":"2026090306593993700_cit165","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/adfm.201002314","article-title":"Multifunctional\nNanoparticles\nComposed of A Poly(dl-lactide-coglycolide) Core and A Paramagnetic\nLiposome Shell for Simultaneous Magnetic Resonance Imaging and Targeted\nTherapeutics","volume":"21","author":"Liao","year":"2011","journal-title":"Adv. Funct. Mater."},{"key":"2026090306593993700_cit166","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202529443","article-title":"Poly(lactic-co-glycolic\nacid) Nanoparticles for IL-12 Self-Amplifying RNA Delivery in Glioblastoma\nModels","volume":"36","author":"Hameedat","year":"2025","journal-title":"Adv. Funct. Mater"},{"key":"2026090306593993700_cit167","doi-asserted-by":"publisher","first-page":"101060","DOI":"10.1016\/j.ctarc.2025.101060","article-title":"Advances in personalized cancer vaccine to nanotechnology\ninnovations","volume":"46","author":"Alaqeel","year":"2026","journal-title":"Cancer Treat. Res. Commun."},{"issue":"24","key":"2026090306593993700_cit168","doi-asserted-by":"publisher","first-page":"24539","DOI":"10.1021\/acsnano.3c08219","article-title":"Bioinspired Spatiotemporal\nManagement toward RNA Therapies","volume":"17","author":"Ma","year":"2023","journal-title":"ACS Nano"},{"issue":"5","key":"2026090306593993700_cit169","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems\nfor RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"issue":"8","key":"2026090306593993700_cit170","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1021\/acsnano.4c14041","article-title":"Targeted Delivery\nof mRNA with Polymer-Lipid Nanoparticles for In Vivo Base Editing","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"issue":"4","key":"2026090306593993700_cit171","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1007\/s11051-014-2342-1","article-title":"Bioapplications\nof\npoly(amidoamine) (PAMAM) dendrimers in nanomedicine","volume":"16","author":"Pourianazar","year":"2014","journal-title":"J. Nanopart. Res."},{"key":"2026090306593993700_cit172","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jconrel.2020.06.030","article-title":"Theranostic dendrimer-based lipid\nnanoparticles containing\nPEGylated BODIPY dyes for tumor imaging and systemic mRNA delivery\nin vivo","volume":"325","author":"Xiong","year":"2020","journal-title":"J. Controlled Release"},{"issue":"52","key":"2026090306593993700_cit173","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201805308","article-title":"Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic\nFAH mRNA to Normalize Liver Function and Extend Survival in a Mouse\nModel of Hepatorenal Tyrosinemia Type I","volume":"30","author":"Cheng","year":"2018","journal-title":"Adv.\nMater."},{"issue":"45","key":"2026090306593993700_cit174","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202203629","article-title":"Polymeric Dendrimers\nas Nanocarrier Vectors for Neurotheranostics","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"issue":"3","key":"2026090306593993700_cit175","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10486","article-title":"Galactosylated hydroxyl-polyamidoamine\ndendrimer targets hepatocytes and improves therapeutic outcomes in\na severe model of acetaminophen poisoning-induced liver failure","volume":"8","author":"Porterfield","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"29","key":"2026090306593993700_cit176","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1600299113","article-title":"Dendrimer-RNA nanoparticles\ngenerate protective immunity against lethal Ebola, H1N1 influenza,\nand Toxoplasma gondii challenges with a single dose","volume":"113","author":"Chahal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"44","key":"2026090306593993700_cit177","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2304966120","article-title":"Inhaled mRNA nanoparticles dual-targeting cancer cells\nand macrophages in the lung for effective transfection","volume":"120","author":"Tang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"2026090306593993700_cit178","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1021\/bm501532e","article-title":"Advanced nanocarriers\nbased on heparin and its derivatives for cancer management","volume":"16","author":"Yang","year":"2015","journal-title":"Biomacromolecules"},{"issue":"3","key":"2026090306593993700_cit179","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/pharmaceutics16030370","article-title":"Alginate-Based\nEncapsulation Fabrication\nTechnique for Drug Delivery: An Updated Review of Particle Type, Formulation\nTechnique, Pharmaceutical Ingredient, and Targeted Delivery System","volume":"16","author":"Lai","year":"2024","journal-title":"Pharmaceutics"},{"issue":"35","key":"2026090306593993700_cit180","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.1039\/D1TB00628B","article-title":"Polysaccharide\nnanoparticles:\nfrom fabrication to applications","volume":"9","author":"Plucinski","year":"2021","journal-title":"J. Mater.\nChem. B"},{"key":"2026090306593993700_cit181","doi-asserted-by":"publisher","first-page":"117999","DOI":"10.1016\/j.carbpol.2021.117999","article-title":"Recent advances in dextran-based\ndrug delivery systems: From fabrication strategies to applications","volume":"264","author":"Hu","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"18","key":"2026090306593993700_cit182","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1021\/la500905z","article-title":"Dextran\u2013Peptide\nHybrid for\nEfficient Gene Delivery","volume":"30","author":"Tang","year":"2014","journal-title":"Langmuir"},{"issue":"4","key":"2026090306593993700_cit183","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.drudis.2020.12.017","article-title":"Biomimetic bacterial and viral-based\nnanovesicles for\ndrug delivery, theranostics, and vaccine applications","volume":"26","author":"Loo","year":"2021","journal-title":"Drug Discovery Today"},{"issue":"Pt B","key":"2026090306593993700_cit184","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","article-title":"Production of virus-like\nparticles for vaccines","volume":"39","author":"Fuenmayor","year":"2017","journal-title":"New Biotechnol."},{"key":"2026090306593993700_cit185","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-chembioeng-100724-084456","article-title":"Protein Vesicles as\nEmerging Platforms\nfor Drug Delivery, Vaccines, and Immunotherapy","volume":"2026","author":"Tasnim","year":"2026","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"issue":"2","key":"2026090306593993700_cit186","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/biomimetics11020150","article-title":"Virus Biomimetic-Delivery\nSystems for the Production of Vaccines","volume":"11","author":"Barbinta-Patrascu","year":"2026","journal-title":"Biomimetics"},{"issue":"9","key":"2026090306593993700_cit187","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-like particle\nvaccinology,\nfrom bench to bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"2026090306593993700_cit188","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12951-021-00806-7","article-title":"Virus-like particles:\npreparation, immunogenicity and their roles as nanovaccines and drug\nnanocarriers","volume":"19","author":"Nooraei","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"2026090306593993700_cit189","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/life11040334","article-title":"In Vitro Assembly of Virus-Like Particles\nand Their Applications","volume":"11","author":"Le","year":"2021","journal-title":"Life"},{"issue":"3","key":"2026090306593993700_cit190","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10492","article-title":"Nanomaterials for mRNA-based therapeutics:\nChallenges and opportunities","volume":"8","author":"Li","year":"2023","journal-title":"Bioeng. Transl.\nMed."},{"issue":"1","key":"2026090306593993700_cit191","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.chembiol.2023.09.015","article-title":"Highly efficient\ncellular expression\nof circular mRNA enables prolonged protein expression","volume":"31","author":"Unti","year":"2024","journal-title":"Cell Chem. Biol."},{"issue":"29","key":"2026090306593993700_cit192","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305896120","article-title":"Increased\nneutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine\nforming virus-like particles","volume":"120","author":"Zhang","year":"2023","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"issue":"Pt A","key":"2026090306593993700_cit193","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.ijbiomac.2022.04.114","article-title":"Developing all-in-one\nvirus-like particles for Cas9 mRNA\/single guide RNA co-delivery and\naptamer-containing lentiviral vectors for improved gene expression","volume":"209","author":"Yadav","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"2026090306593993700_cit194","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1021\/accountsmr.3c00050","article-title":"Rational Design\nof Virus-like Particles for Nanomedicine","volume":"4","author":"Shan","year":"2023","journal-title":"Acc.\nMater. Res."},{"issue":"10","key":"2026090306593993700_cit195","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1038\/s41590-023-01597-9","article-title":"Molecular\nbasis for potent B cell responses to antigen displayed on particles\nof viral size","volume":"24","author":"Brooks","year":"2023","journal-title":"Nat. Immunol."},{"issue":"1","key":"2026090306593993700_cit196","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1038\/s41467-023-40788-8","article-title":"Cell type-specific\ndelivery by modular envelope design","volume":"14","author":"Strebinger","year":"2023","journal-title":"Nat. Commun."},{"key":"2026090306593993700_cit197","doi-asserted-by":"publisher","first-page":"1123805","DOI":"10.3389\/fimmu.2023.1123805","article-title":"Platforms,\nadvances,\nand technical challenges in virus-like particles-based vaccines","volume":"14","author":"Gupta","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"2026090306593993700_cit198","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering\nprecision nanoparticles\nfor drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"2026090306593993700_cit199","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s44386-025-00037-y","article-title":"Advancements\nin RNA-based therapies from bench to bedside","volume":"3","author":"Singh","year":"2026","journal-title":"Npj Drug Discovery"},{"issue":"8","key":"2026090306593993700_cit200","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties\nof engineered\nnanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"2026090306593993700_cit201","doi-asserted-by":"publisher","first-page":"12868","DOI":"10.1038\/ncomms12868","article-title":"Local microRNA\ndelivery targets Palladin and prevents metastatic breast cancer","volume":"7","author":"Gilam","year":"2016","journal-title":"Nat. Commun."},{"issue":"27","key":"2026090306593993700_cit202","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1002\/adfm.201501283","article-title":"Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide\nnanoparticles to tumour-associated macrophages and cancer cells","volume":"25","author":"Conde","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"2026090306593993700_cit203","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of\nnanoparticle\ncellular uptake, intracellular trafficking, and kinetics in nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv. Drug Delivery Rev."},{"issue":"1","key":"2026090306593993700_cit204","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41467-022-28627-8","article-title":"Fast microwave\nheating-based one-step synthesis of DNA and RNA modified gold nanoparticles","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"2026090306593993700_cit205","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075369","article-title":"Inhibition of Xenograft\ntumor growth by gold nanoparticle-DNA\noligonucleotide conjugates-assisted delivery of BAX mRNA","volume":"8","author":"Yeom","year":"2013","journal-title":"PLoS One"},{"key":"2026090306593993700_cit206","doi-asserted-by":"publisher","DOI":"10.2174\/0115665232425141251028050552","article-title":"Targeted TP53 and KRAS Modulation\nVia AuNP-Mediated RNA Delivery Suppresses Cancer Progression","author":"Du\u0308ndar","year":"2026","journal-title":"Curr. Gene Ther."},{"key":"2026090306593993700_cit207","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.actbio.2017.11.049","article-title":"Hollow mesoporous\nzirconia delivery\nsystem for biomineralization precursors","volume":"67","author":"Huang","year":"2018","journal-title":"Acta\nBiomater."},{"key":"2026090306593993700_cit208","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.addr.2020.06.020","article-title":"Delivery of drugs,\nproteins, and nucleic acids using inorganic nanoparticles","volume":"156","author":"Luther","year":"2020","journal-title":"Adv. Drug Delivery Rev."},{"issue":"3","key":"2026090306593993700_cit209","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/10717544.2013.838715","article-title":"Synthesis and surface modification\nof mesoporous silica nanoparticles and its application as carriers\nfor sustained drug delivery","volume":"21","author":"Ahmadi","year":"2014","journal-title":"Drug Delivery"},{"issue":"10","key":"2026090306593993700_cit210","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1021\/nn900918w","article-title":"Polyethyleneimine\ncoating enhances the cellular uptake of mesoporous silica nanoparticles\nand allows safe delivery of siRNA and DNA constructs","volume":"3","author":"Xia","year":"2009","journal-title":"ACS Nano"},{"issue":"5","key":"2026090306593993700_cit211","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/anie.201506179","article-title":"Stimulation\nof In Vivo\nAntitumor Immunity with Hollow Mesoporous Silica Nanospheres","volume":"55","author":"Wang","year":"2016","journal-title":"Angew. Chem."},{"issue":"31","key":"2026090306593993700_cit212","doi-asserted-by":"publisher","first-page":"34658","DOI":"10.1021\/acsami.0c09484","article-title":"Hollow Mesoporous\nSilica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer\nVaccine","volume":"12","author":"Lee","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"2026090306593993700_cit213","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/2230-973X.160844","article-title":"Mesoporous\nsilica nanoparticles in target drug delivery system: A review","volume":"5","author":"Bharti","year":"2015","journal-title":"Int. J. Pharmaceut. Invest."},{"issue":"1","key":"2026090306593993700_cit214","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles\nfor cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Trans. Target. Ther."},{"issue":"22","key":"2026090306593993700_cit215","doi-asserted-by":"publisher","first-page":"8852","DOI":"10.1021\/acs.nanolett.2c02691","article-title":"Magnetically Induced Brownian Motion of Iron Oxide\nNanocages in Alternating Magnetic Fields and Their Application for\nEfficient siRNA Delivery","volume":"22","author":"Kang","year":"2022","journal-title":"Nano Lett."},{"issue":"555","key":"2026090306593993700_cit216","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An\nAlphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing\nantibody and T cell responses in mice and nonhuman primates","volume":"12","author":"Erasmus","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"2026090306593993700_cit217","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41467-026-69017-8","article-title":"Engineered internal architecture of core-shell lipid\nnanoparticles\npromotes efficient mRNA endosomal release","volume":"17","author":"Li","year":"2026","journal-title":"Nat.\nCommun."},{"issue":"1","key":"2026090306593993700_cit218","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41467-024-55223-9","article-title":"Aptamer-conjugated\ngold nanoparticles enable oligonucleotide\ndelivery into muscle stem cells to promote regeneration of dystrophic\nmuscles","volume":"16","author":"Millozzi","year":"2025","journal-title":"Nat. Commun."},{"key":"2026090306593993700_cit219","doi-asserted-by":"publisher","first-page":"102921","DOI":"10.1016\/j.mtbio.2026.102921","article-title":"Silica nanoparticles as advanced\nplatforms for nucleic acid delivery","volume":"37","author":"Fanarraga","year":"2026","journal-title":"Mater.\nToday Bio."},{"issue":"1","key":"2026090306593993700_cit220","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10544-024-00698-y","article-title":"SPIONs: Superparamagnetic\niron oxide-based\nnanoparticles for the delivery of microRNAi-therapeutics in cancer","volume":"26","author":"Kara","year":"2024","journal-title":"Biomed. Microdev."},{"issue":"1","key":"2026090306593993700_cit221","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13045-024-01628-4","article-title":"Personalized\nnanovaccines for treating\nsolid cancer metastases","volume":"17","author":"Feng","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"2026090306593993700_cit222","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/17425247.2019.1662786","article-title":"Overcoming\nthe stability, toxicity, and biodegradation challenges of tumor stimuli-responsive\ninorganic nanoparticles for delivery of cancer therapeutics","volume":"16","author":"Paris","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"2026090306593993700_cit223","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.addr.2018.06.017","article-title":"Strategic design\nof extracellular\nvesicle drug delivery systems","volume":"130","author":"Armstrong","year":"2018","journal-title":"Adv. Drug Delivery\nRev."},{"key":"2026090306593993700_cit224","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis,\nsecretion, and intercellular interactions of exosomes and other extracellular\nvesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"5","key":"2026090306593993700_cit225","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101557","article-title":"RNA and Protein\nDelivery by Cell-Secreted and Bioengineered Extracellular Vesicles","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"2026090306593993700_cit226","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles\nand their physiological functions","volume":"4","author":"Ya\u0301n\u0303ez-Mo\u0301","year":"2015","journal-title":"J. Extracell.\nVesicles"},{"issue":"8","key":"2026090306593993700_cit227","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1515\/revneuro-2020-0144","article-title":"Roles of glia-derived\nextracellular vesicles in central nervous system diseases: an update","volume":"32","author":"Sun","year":"2021","journal-title":"Rev. Neurosci."},{"issue":"26","key":"2026090306593993700_cit228","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.7150\/thno.37097","article-title":"Extracellular\nvesicle-based drug\ndelivery systems for cancer treatment","volume":"9","author":"Walker","year":"2019","journal-title":"Theranostics"},{"issue":"10","key":"2026090306593993700_cit229","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cells12101416","article-title":"Current Strategies\nfor Exosome Cargo Loading and Targeting\nDelivery","volume":"12","author":"Zeng","year":"2023","journal-title":"Cells"},{"key":"2026090306593993700_cit230","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.biochi.2019.07.009","article-title":"The relationship\nbetween molecular content of mesenchymal stem cells derived exosomes\nand their potentials: Opening the way for exosomes based therapeutics","volume":"165","author":"Jafari","year":"2019","journal-title":"Biochimie"},{"issue":"8","key":"2026090306593993700_cit231","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.7150\/thno.93755","article-title":"Bioinspired cellular membrane-derived\nvesicles for mRNA delivery","volume":"14","author":"Xu","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"2026090306593993700_cit232","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes\nproduced by implanted\ncells intracerebrally deliver therapeutic cargo for Parkinson\u2019s\ndisease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"2026090306593993700_cit233","doi-asserted-by":"publisher","first-page":"101266","DOI":"10.1016\/j.jbc.2021.101266","article-title":"Exosome-mediated mRNA delivery in\nvivo is safe and can be used to induce SARS-CoV-2 immunity","volume":"297","author":"Tsai","year":"2021","journal-title":"J. Biol. Chem."},{"key":"2026090306593993700_cit234","doi-asserted-by":"publisher","first-page":"1435426","DOI":"10.3389\/fimmu.2024.1435426","article-title":"Exosomes:\nthe next\nfrontier in vaccine development and delivery","volume":"15","author":"Tan","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"2026090306593993700_cit235","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular\nvesicles\nas a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"2026090306593993700_cit236","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10555-025-10287-x","article-title":"Integrins from extracellular vesicles\nas players in tumor microenvironment and metastasis","volume":"44","author":"Ciobanasu","year":"2025","journal-title":"Cancer Metastasis Rev."},{"issue":"13","key":"2026090306593993700_cit237","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12167","article-title":"High TSPAN8 expression\nin epithelial cancer cell-derived small extracellular vesicles promote\nconfined diffusion and pronounced uptake","volume":"10","author":"Wang","year":"2021","journal-title":"J.\nExtracell. Vesicles"},{"issue":"29","key":"2026090306593993700_cit238","doi-asserted-by":"publisher","first-page":"41666","DOI":"10.1021\/acsami.5c06927","article-title":"Microfluidic Production of Exosome-Mimicking Lipid\nNanoparticles for Enhanced RNA Delivery: Role of Exosomal Proteins","volume":"17","author":"Maeki","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026090306593993700_cit239","doi-asserted-by":"publisher","first-page":"118813","DOI":"10.1016\/j.biopha.2025.118813","article-title":"Quantitative\nand qualitative comparison of mRNA loading techniques into extracellular\nvesicles","volume":"193","author":"Guarro","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"2026090306593993700_cit240","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","article-title":"Extracellular vesicle-based drug\noverview: research\nlandscape, quality control and nonclinical evaluation strategies","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Trans. Target. Ther."},{"issue":"11","key":"2026090306593993700_cit241","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1016\/j.tibtech.2025.06.020","article-title":"Extracellular vesicle manufacture\nvia FACTORY: fully automated collection technology and optimum machinery\nfor clinical translational applications","volume":"43","author":"Liu","year":"2025","journal-title":"Trends\nBiotechnol."},{"key":"2026090306593993700_cit242","doi-asserted-by":"publisher","first-page":"218034","DOI":"10.1016\/j.canlet.2025.218034","article-title":"Dendritic cells-derived extracellular vesicles in tumourigenesis:\nFrom biological roles to clinical implications","volume":"633","author":"Chen","year":"2025","journal-title":"Cancer Lett."},{"issue":"5","key":"2026090306593993700_cit243","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s44222-025-00277-7","article-title":"Extracellular\nvesicles for the delivery of gene therapy","volume":"3","author":"Di Ianni","year":"2025","journal-title":"Nat.\nRev. Bioeng."},{"issue":"26","key":"2026090306593993700_cit244","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1016\/j.cell.2025.11.023","article-title":"Distinct\ncomponents of mRNA vaccines cooperate to instruct\nefficient germinal center responses","volume":"188","author":"Castan\u0303o","year":"2025","journal-title":"Cell"},{"key":"2026090306593993700_cit245","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mattod.2025.11.029","article-title":"Supramolecular\nlipid nanoparticle reprograms tumor microenvironment by cucurbit[7]uril-based\nhost\u2013guest recognition for STING-activating cancer immunotherapy","volume":"92","author":"Feng","year":"2026","journal-title":"Mater. Today"},{"key":"2026090306593993700_cit246","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12951-026-04562-4","article-title":"Lipid nanoparticle-mediated co-delivery\nof IL-33 mRNA and STING agonist modulates the breast cancer microenvironment\nand potentiates immunotherapy","volume":"24","author":"Zhao","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"6525","key":"2026090306593993700_cit247","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA\nvaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"issue":"33","key":"2026090306593993700_cit248","doi-asserted-by":"publisher","DOI":"10.1002\/advs.75548","article-title":"Decoding Undesirable\nInflammatory\nResponses of Nucleic Acid-Delivering Lipid Nanoparticles","volume":"13","author":"Hu","year":"2026","journal-title":"Adv. Sci."},{"issue":"4","key":"2026090306593993700_cit249","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nnano.2017.61","article-title":"Nanomedicine: Evolution of the nanoparticle\ncorona","volume":"12","author":"Hadjidemetriou","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"32","key":"2026090306593993700_cit250","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201901556","article-title":"Nanoparticle\nCharacterization: What to Measure?","volume":"31","author":"Modena","year":"2019","journal-title":"Adv. Mater."},{"issue":"8","key":"2026090306593993700_cit251","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1021\/acs.accounts.7b00078","article-title":"Chemical\nReactions of Molecules Promoted\nand Simultaneously Imaged by the Electron Beam in Transmission Electron\nMicroscopy","volume":"50","author":"Skowron","year":"2017","journal-title":"Acc. Chem. Res."},{"issue":"8","key":"2026090306593993700_cit252","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1021\/acs.accounts.7b00318","article-title":"Transmission Electron\nMicroscopy for Chemists","volume":"50","author":"Nakamura","year":"2017","journal-title":"Acc. Chem. Res."},{"issue":"27","key":"2026090306593993700_cit253","doi-asserted-by":"publisher","first-page":"12871","DOI":"10.1039\/C8NR02278J","article-title":"Characterization\ntechniques for nanoparticles: comparison and complementarity upon\nstudying nanoparticle properties","volume":"10","author":"Mourdikoudis","year":"2018","journal-title":"Nanoscale"},{"issue":"17","key":"2026090306593993700_cit254","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201907418","article-title":"Multimodal Characterization\nof Resin Embedded and Sliced Polymer Nanoparticles by Means of Tip-Enhanced\nRaman Spectroscopy and Force-Distance Curve Based Atomic Force Microscopy","volume":"16","author":"Ho\u0308ppener","year":"2020","journal-title":"Small"},{"issue":"5","key":"2026090306593993700_cit255","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s11095-016-1867-7","article-title":"Multimodal\nDispersion of Nanoparticles:\nA Comprehensive Evaluation of Size Distribution with 9 Size Measurement\nMethods","volume":"33","author":"Varenne","year":"2016","journal-title":"Pharm. Res."},{"issue":"11","key":"2026090306593993700_cit256","doi-asserted-by":"publisher","first-page":"7331","DOI":"10.1021\/acs.chemrev.6b00815","article-title":"Single\nParticle\nTracking: From Theory to Biophysical Applications","volume":"117","author":"Shen","year":"2017","journal-title":"Chem. Rev."},{"issue":"6","key":"2026090306593993700_cit257","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1021\/acsmacrolett.7b00229","article-title":"Charge\nHas a Marked Influence on Hyperbranched Polymer Nanoparticle Association\nin Whole Human Blood","volume":"6","author":"Glass","year":"2017","journal-title":"ACS Macro Lett."},{"issue":"5","key":"2026090306593993700_cit258","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.7150\/thno.69094","article-title":"Characterization and modulation of\nsurface charges to enhance extracellular vesicle isolation in plasma","volume":"12","author":"Woo","year":"2022","journal-title":"Theranostics"},{"key":"2026090306593993700_cit259","doi-asserted-by":"publisher","first-page":"117749","DOI":"10.1016\/j.watres.2021.117749","article-title":"Stability\nof Oxygen Nanobubbles under Freshwater Conditions","volume":"206","author":"Soyluoglu","year":"2021","journal-title":"Water Res."},{"issue":"1","key":"2026090306593993700_cit260","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s40820-014-0020-6","article-title":"High-Throughput Screening of Nanoparticle-Stabilizing\nLigands: Application to Preparing Antimicrobial Curcumin Nanoparticles\nby Antisolvent Precipitation","volume":"7","author":"Shlar","year":"2015","journal-title":"Nano Micro Lett."},{"issue":"14","key":"2026090306593993700_cit261","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1039\/D1TB02549J","article-title":"Engineering\nsurface patterns on nanoparticles: new insights into nano-bio interactions","volume":"10","author":"Hu","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"2026090306593993700_cit262","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41467-022-28279-8","article-title":"Combining\np53 mRNA nanotherapy with immune\ncheckpoint blockade reprograms the immune microenvironment for effective\ncancer therapy","volume":"13","author":"Xiao","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"2026090306593993700_cit263","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0092-8674(77)90272-0","article-title":"Sizing and mapping of early adenovirus\nmRNAs by gel electrophoresis of S1 endonuclease-digested hybrids","volume":"12","author":"Berk","year":"1977","journal-title":"Cell"},{"issue":"29","key":"2026090306593993700_cit264","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1021\/ja801994z","article-title":"Changes in conformational\ndynamics of mRNA upon AtGRP7 binding studied by fluorescence correlation\nspectroscopy","volume":"130","author":"Schu\u0308ttpelz","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"43","key":"2026090306593993700_cit265","doi-asserted-by":"publisher","first-page":"17432","DOI":"10.1021\/acs.analchem.4c04607","article-title":"Saponin is\nEssential for the Isolation of Proteins and RNA from Biological Nanoparticles","volume":"96","author":"Brezgin","year":"2024","journal-title":"Anal. Chem."},{"issue":"9","key":"2026090306593993700_cit266","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh8689","article-title":"Colocalization of protein\nand microRNA markers reveals unique extracellular vesicle subpopulations\nfor early cancer detection","volume":"10","author":"Li","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"2026090306593993700_cit267","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jfutfo.2023.05.006","article-title":"Inorganic\nvirus-like\nnanoparticles for biomedical applications: a minireview","volume":"4","author":"Zhao","year":"2024","journal-title":"J. Future Foods"},{"key":"2026090306593993700_cit268","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jconrel.2022.01.032","article-title":"Metal-ion coordinated self-assembly\nof human insulin directs kinetics of insulin release as determined\nby preclinical SPECT\/CT imaging","volume":"343","author":"Engudar","year":"2022","journal-title":"J. Controlled\nRelease"},{"issue":"1","key":"2026090306593993700_cit269","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s43586-023-00258-3","article-title":"Best practices\nfor characterizing RNA lipid nanoparticles","volume":"3","author":"Khan","year":"2023","journal-title":"Nat. Rev. Methods Primers"},{"issue":"7","key":"2026090306593993700_cit270","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112696119","article-title":"Intravesical delivery of KDM6A-mRNA via mucoadhesive\nnanoparticles inhibits the metastasis of bladder cancer","volume":"119","author":"Kong","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"523","key":"2026090306593993700_cit271","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw1565","article-title":"Synthetic mRNA nanoparticle-mediated\nrestoration of p53 tumor suppressor sensitizes p53-deficient cancers\nto mTOR inhibition","volume":"11","author":"Kong","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"2026090306593993700_cit272","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nmat4707","article-title":"Local triple-combination\ntherapy results in tumour regression and prevents recurrence in a\ncolon cancer model","volume":"15","author":"Conde","year":"2016","journal-title":"Nat. Mater."},{"issue":"10","key":"2026090306593993700_cit273","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.1021\/acsnano.4c00550","article-title":"Modulation\nof Dendritic Cell Function via Nanoparticle-Induced Cytosolic Calcium\nChanges","volume":"18","author":"Cao","year":"2024","journal-title":"ACS Nano"},{"issue":"47","key":"2026090306593993700_cit274","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202207486","article-title":"Nanomaterials-Mediated\nCo-Stimulation of Toll-Like\nReceptors and CD40 for Antitumor Immunity","volume":"34","author":"Yan","year":"2022","journal-title":"Adv.\nMater."},{"key":"2026090306593993700_cit275","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bioactmat.2022.07.027","article-title":"Nanodrug enhances\npost-ablation immunotherapy\nof hepatocellular carcinoma via promoting dendritic cell maturation\nand antigen presentation","volume":"21","author":"Xiao","year":"2023","journal-title":"Bioact. Mater."},{"issue":"37","key":"2026090306593993700_cit276","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413014","article-title":"Potentiating the Efficacy\nof mRNA Vaccines through\nNIR-II Imaging-Guided Precise Vaccination","volume":"12","author":"Li","year":"2025","journal-title":"Adv.\nSci."},{"issue":"6","key":"2026090306593993700_cit277","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41551-023-01083-5","article-title":"Shortwave-infrared-light-emitting\nprobes for the in vivo tracking of cancer vaccines and the elicited\nimmune responses","volume":"8","author":"Ren","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"2026090306593993700_cit278","doi-asserted-by":"publisher","first-page":"102083","DOI":"10.1016\/j.omtn.2023.102083","article-title":"E., mRNA vaccine trafficking\nand resulting protein expression after intramuscular administration","volume":"35","author":"Hassett","year":"2024","journal-title":"Molecular Therapy. Nucleic Acids"},{"key":"2026090306593993700_cit279","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2023.03.036","article-title":"STING agonist-loaded\nmesoporous manganese-silica nanoparticles for vaccine applications","volume":"357","author":"Xu","year":"2023","journal-title":"J. Controlled Release"},{"key":"2026090306593993700_cit280","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.mtbio.2024.101018","article-title":"Mn-phenolic networks as synergistic carrier for STING\nagonists in tumor immunotherapy","volume":"26","author":"Meng","year":"2024","journal-title":"Mater. Today\nBio"},{"issue":"2","key":"2026090306593993700_cit281","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202406950","article-title":"Advancing Cancer Vaccines with Radionuclide Imaging","volume":"21","author":"Cheng","year":"2025","journal-title":"Small"},{"issue":"15","key":"2026090306593993700_cit282","doi-asserted-by":"publisher","first-page":"18590","DOI":"10.1021\/acsami.2c20846","article-title":"Aptamer-Functionalized\nNanovaccines: Targeting In Vivo\nDC Subsets for Enhanced Antitumor Immunity","volume":"15","author":"Zheng","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026090306593993700_cit283","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.actbio.2022.12.066","article-title":"Facile preparation\nof a metal-phenolic network-based lymph node targeting nanovaccine\nfor antitumor immunotherapy","volume":"158","author":"Su","year":"2023","journal-title":"Acta Biomater."},{"issue":"1","key":"2026090306593993700_cit284","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biomedicines12010059","article-title":"Biodistribution\nof RNA Vaccines and of Their Products: Evidence from Human and Animal\nStudies","volume":"12","author":"Pateev","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"2026090306593993700_cit285","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12951-023-02134-4","article-title":"Surface antibody changes\nprotein corona both in human and mouse serum but not final opsonization\nand elimination of targeted polymeric nanoparticles","volume":"21","author":"Capolla","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"2026090306593993700_cit286","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12951-025-03565-x","article-title":"Engineered protein corona sustains\nstealth functionality of nanocarriers in plasma","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"2026090306593993700_cit287","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12989-017-0206-4","article-title":"Evaluating\nthe potential\nof gold, silver, and silica nanoparticles to saturate mononuclear\nphagocytic system tissues under repeat dosing conditions","volume":"14","author":"Weaver","year":"2017","journal-title":"Part. Fibre Toxicol."},{"issue":"11","key":"2026090306593993700_cit288","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational\nframework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"2026090306593993700_cit289","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41565-022-01071-x","article-title":"Applying lessons learned from nanomedicines\nto understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2\nvaccines","volume":"17","author":"Szebeni","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"Supplement_1","key":"2026090306593993700_cit290","doi-asserted-by":"publisher","first-page":"vkaf283.2357","DOI":"10.1093\/jimmun\/vkaf283.2357","article-title":"Antigen-specific\ntolerogenic mRNA-LNPs for the treatment of autoimmunity 4721","volume":"214","author":"Kenison-White","year":"2025","journal-title":"J. Immunol."},{"issue":"5","key":"2026090306593993700_cit291","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","article-title":"Visualization of early events in mRNA vaccine delivery\nin non-human primates via PET-CT and near-infrared imaging","volume":"3","author":"Lindsay","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"2026090306593993700_cit292","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ymthe.2020.01.002","article-title":"Aerosol Delivery of Synthetic mRNA\nto Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing\nAntibodies against HIV","volume":"28","author":"Lindsay","year":"2020","journal-title":"Mol. Ther."},{"key":"2026090306593993700_cit293","doi-asserted-by":"publisher","first-page":"100766","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Three decades\nof messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nano Today"},{"key":"2026090306593993700_cit294","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics\nof nucleoside-modified\nmRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Controlled Release"},{"issue":"6","key":"2026090306593993700_cit295","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA Vaccines\nProtect against Zika Virus Infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"2026090306593993700_cit296","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/82_2020_217","article-title":"Formulation\nand Delivery Technologies for mRNA Vaccines","volume":"440","author":"Zeng","year":"2020","journal-title":"Curr. Topics Microbiol. Immunol."},{"issue":"1","key":"2026090306593993700_cit297","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s43586-023-00246-7","article-title":"Nanotechnology-based\nmRNA vaccines","volume":"3","author":"Chen","year":"2023","journal-title":"Nat. Rev.\nMethods Primers"},{"issue":"1","key":"2026090306593993700_cit298","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1038\/s41467-018-06508-3","article-title":"Engineered mRNA-expressed antibodies\nprevent respiratory\nsyncytial virus infection","volume":"9","author":"Tiwari","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"2026090306593993700_cit299","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijpharm.2017.08.110","article-title":"Development of novel\ndouble-decker microneedle patches for transcutaneous\nvaccine delivery","volume":"532","author":"Ono","year":"2017","journal-title":"Int. J. Pharm."},{"key":"2026090306593993700_cit300","doi-asserted-by":"publisher","first-page":"115419","DOI":"10.1016\/j.addr.2024.115419","article-title":"Advances in the design and delivery of RNA vaccines for infectious\ndiseases","volume":"213","author":"Lokras","year":"2024","journal-title":"Adv. Drug Delivery Rev."},{"issue":"11","key":"2026090306593993700_cit301","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"A., mRNA vaccines\nfor infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"11","key":"2026090306593993700_cit302","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious\ndiseases\n- advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat.\nRev. Drug Discovery"},{"issue":"24","key":"2026090306593993700_cit303","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1016\/j.cell.2025.08.027","article-title":"Mining\nthe CD4 antigen repertoire for next-generation tuberculosis vaccines","volume":"188","author":"Vidal","year":"2025","journal-title":"Cell"},{"issue":"1","key":"2026090306593993700_cit304","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41541-023-00679-x","article-title":"A mosquito\nAgTRIO mRNA vaccine contributes to immunity against malaria","volume":"8","author":"Chuang","year":"2023","journal-title":"Npj Vaccines"},{"issue":"1","key":"2026090306593993700_cit305","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1038\/s41467-023-39376-7","article-title":"Safety and immunogenicity\nof a phase 1\/2 randomized clinical trial of a quadrivalent, mRNA-based\nseasonal influenza vaccine (mRNA-1010) in healthy adults: interim\nanalysis","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"2026090306593993700_cit306","doi-asserted-by":"publisher","first-page":"126847","DOI":"10.1016\/j.vaccine.2025.126847","article-title":"A phase 3 randomized safety and immunogenicity\ntrial of mRNA-1010 seasonal influenza vaccine in adults","volume":"50","author":"Soens","year":"2025","journal-title":"Vaccine"},{"issue":"24","key":"2026090306593993700_cit307","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy\nand Safety of an mRNA-Based RSV PreF Vaccine\nin Older Adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"2026090306593993700_cit308","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.ymthe.2019.08.007","article-title":"Immunogenicity of RNA Replicons Encoding\nHIV Env Immunogens Designed for Self-Assembly into Nanoparticles","volume":"27","author":"Melo","year":"2019","journal-title":"Mol. Ther."},{"issue":"3","key":"2026090306593993700_cit309","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV Vaccine Design to Target Germline Precursors of\nGlycan-Dependent Broadly Neutralizing Antibodies","volume":"45","author":"Steichen","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"2026090306593993700_cit310","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1038\/s41467-023-41628-5","article-title":"mRNA vaccines encoding fusion proteins of monkeypox\nvirus antigens\nprotect mice from vaccinia virus challenge","volume":"14","author":"Hou","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"2026090306593993700_cit311","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox\nvirus vaccine (BNT166) protects mice and macaques from orthopoxvirus\ndisease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"issue":"8","key":"2026090306593993700_cit312","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.vaccine.2020.12.070","article-title":"Proof-of-concept\nof a low-dose unmodified mRNA-based rabies vaccine formulated with\nlipid nanoparticles in human volunteers: A phase 1 trial","volume":"39","author":"Aldrich","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"2026090306593993700_cit313","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/infdis\/jiad593","article-title":"Human Cytomegalovirus\nmRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization\nand Higher Antibody-Dependent Cellular Cytotoxicity Responses Than\nthe gB\/MF59 Vaccine","volume":"230","author":"Hu","year":"2024","journal-title":"J. Infect. Dis."},{"issue":"2","key":"2026090306593993700_cit314","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized,\ndouble-blind, Phase 1 trial of an alphavirus replicon vaccine for\ncytomegalovirus in CMV seronegative adult volunteers","volume":"28","author":"Bernstein","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"2026090306593993700_cit315","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41541-022-00590-x","article-title":"A phase I\/II randomized,\ndouble-blinded, placebo-controlled trial of a self-amplifying Covid-19\nmRNA vaccine","volume":"7","author":"Low","year":"2022","journal-title":"Npj Vaccines"},{"key":"2026090306593993700_cit316","doi-asserted-by":"publisher","first-page":"101262","DOI":"10.1016\/j.eclinm.2021.101262","article-title":"Safety and immunogenicity\nof a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase\nI, dose-ranging trial","volume":"44","author":"Pollock","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026090306593993700_cit317","doi-asserted-by":"publisher","first-page":"101823","DOI":"10.1016\/j.eclinm.2022.101823","article-title":"COVAC1 phase 2a expanded safety and immunogenicity\nstudy of a self-amplifying RNA vaccine against SARS-CoV-2","volume":"56","author":"Szubert","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2026090306593993700_cit318","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01775-23","article-title":"Circular RNA vaccines\nwith long-term lymph node-targeting delivery stability after lyophilization\ninduce potent and persistent immune responses","volume":"15","author":"Wan","year":"2024","journal-title":"mBio"},{"issue":"12","key":"2026090306593993700_cit319","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41573-024-01041-z","article-title":"Advanced\ntechnologies for the development of infectious\ndisease vaccines","volume":"23","author":"Gupta","year":"2024","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"3","key":"2026090306593993700_cit320","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s44222-023-00131-8","article-title":"Immunoregulatory nanomedicine for\nrespiratory infections","volume":"2","author":"Xiao","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"3","key":"2026090306593993700_cit321","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00041-24","article-title":"mRNA-based HIV-1 vaccines","volume":"37","author":"Ahmed","year":"2024","journal-title":"Clin.\nMicrobiol. Rev."},{"issue":"2","key":"2026090306593993700_cit322","doi-asserted-by":"publisher","first-page":"102935","DOI":"10.1016\/j.omtn.2026.102935","article-title":"Erratum: The potential\nand challenges of circular RNA in the development of vaccines and\ndrugs for emerging infectious diseases","volume":"37","author":"Chen","year":"2026","journal-title":"Molecular\nTherapy. Nucleic Acids"},{"issue":"10427","key":"2026090306593993700_cit323","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab\nversus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942):\na randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"2026090306593993700_cit324","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1038\/d41591-023-00072-0","article-title":"Personalized\nanti-cancer vaccine combining mRNA and\nimmunotherapy tested in melanoma trial","volume":"29","author":"Carvalho","year":"2023","journal-title":"Nat.\nMed."},{"issue":"16_suppl","key":"2026090306593993700_cit325","doi-asserted-by":"publisher","first-page":"TPS8116","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS8116","article-title":"The phase 3 INTerpath-002 study design:\nIndividualized neoantigen therapy (INT) V940 (mRNA-4157) plus pembrolizumab\nvs placebo plus pembrolizumab for resected early-stage non\u2013small-cell\nlung cancer (NSCLC)","volume":"42","author":"Lee","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"2026090306593993700_cit326","doi-asserted-by":"publisher","first-page":"S652","DOI":"10.1016\/j.annonc.2024.08.1001","article-title":"940TiP INTerpath-007:\nA phase II\/III,\nadaptive, randomized study of neoadjuvant and adjuvant pembrolizumab\n(pembro) with V940 (mRNA-4157) for treatment of resectable locally\nadvanced (LA) cutaneous squamous cell carcinoma (cSCC)","volume":"35","author":"Ladwa","year":"2024","journal-title":"Annals Oncol."},{"issue":"5","key":"2026090306593993700_cit327","doi-asserted-by":"publisher","first-page":"TPS610","DOI":"10.1200\/JCO.2025.43.5_suppl.TPS610","article-title":"INTerpath-004: A phase\n2, randomized, double-blind study of adjuvant pembrolizumab (pembro)\nwith V940 (mRNA-4157) or placebo for renal cell carcinoma (RCC)","volume":"43","author":"Motzer","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"5_suppl","key":"2026090306593993700_cit328","doi-asserted-by":"publisher","first-page":"TPS893","DOI":"10.1200\/JCO.2025.43.5_suppl.TPS893","article-title":"Phase 1\/2 INTerpath-005 study: V940\n(mRNA-4157) plus pembrolizumab with or without enfortumab vedotin\n(EV) for resected high-risk muscle-invasive urothelial carcinoma (MIUC)","volume":"43","author":"Sonpavde","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"2026090306593993700_cit329","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12967-024-06033-6","article-title":"mRNA vaccines in the context of cancer\ntreatment: from concept to application","volume":"23","author":"Fu","year":"2025","journal-title":"J. Transl.\nMed."},{"issue":"7","key":"2026090306593993700_cit330","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/10548","article-title":"Cancer\ntherapy using a self-replicating RNA vaccine","volume":"5","author":"Ying","year":"1999","journal-title":"Nat. Med."},{"issue":"2","key":"2026090306593993700_cit331","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ymthe.2020.11.002","article-title":"First-in-Human Phase I Clinical Trial of an SFV-Based\nRNA Replicon Cancer Vaccine against HPV-Induced Cancers","volume":"29","author":"Komdeur","year":"2021","journal-title":"Mol. Ther."},{"issue":"6","key":"2026090306593993700_cit332","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1158\/1078-0432.CCR-24-1662","article-title":"Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive\nHigh-grade Cervical Intraepithelial Neoplasia: A Phase II Trial","volume":"31","author":"Eerkens","year":"2025","journal-title":"Clinical Cancer Res."},{"issue":"14","key":"2026090306593993700_cit333","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/thno.77350","article-title":"Circular RNA cancer\nvaccines drive immunity in hard-to-treat malignancies","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"issue":"20","key":"2026090306593993700_cit334","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302191120","article-title":"Circular RNA vaccine\ninduces potent T cell responses","volume":"120","author":"Amaya","year":"2023","journal-title":"Proc. Natl.\nAcad. Sci. U. S. A."},{"key":"2026090306593993700_cit335","doi-asserted-by":"publisher","first-page":"218459","DOI":"10.1016\/j.canlet.2026.218459","article-title":"A circRNA Neoantigen\nVaccine Elicits Potent Antitumor Immunity and Synergizes with Checkpoint\nBlockade in Melanoma","volume":"648","author":"Wu","year":"2026","journal-title":"Cancer Lett."},{"key":"2026090306593993700_cit336","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001605","article-title":"GPC3-based circular\nRNA vaccine suppresses hepatocellular\ncarcinoma progression by activating adaptive immune responses","author":"Jiang","year":"2025","journal-title":"Hepatology"},{"issue":"41","key":"2026090306593993700_cit337","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn9961","article-title":"Lipopolyplex-formulated mRNA cancer vaccine elicits\nstrong neoantigen-specific T cell responses and antitumor activity","volume":"10","author":"Fan","year":"2024","journal-title":"Sci. Adv."},{"issue":"12","key":"2026090306593993700_cit338","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/s43018-024-00850-w","article-title":"Personalized neoantigen therapy for melanoma immunotherapy","volume":"5","author":"Danelli","year":"2024","journal-title":"Nature Cancer"},{"key":"2026090306593993700_cit339","article-title":"Synthetic\nlinear DNA and functionalized\nLNPs enable rapid manufacture and delivery of personalized mRNA immunotherapies","volume-title":"Journal for ImmunoTherapy of Cancer","author":"Young","year":"1204"},{"issue":"2","key":"2026090306593993700_cit340","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41551-025-01344-5","article-title":"Small circular RNAs as vaccines for cancer immunotherapy","volume":"9","author":"Zhang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"4","key":"2026090306593993700_cit341","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.7150\/thno.104698","article-title":"Optimized circular\nRNA vaccines for superior cancer immunotherapy","volume":"15","author":"Yu","year":"2025","journal-title":"Theranostics"},{"issue":"6","key":"2026090306593993700_cit342","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/j.ymthe.2025.03.034","article-title":"Clinical development of therapeutic\nmRNA applications","volume":"33","author":"Z\u0307ak","year":"2025","journal-title":"Mol. Ther."},{"key":"2026090306593993700_cit343","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s44222-026-00424-8","article-title":"Expanding global access\nto mRNA vaccines","volume":"4","author":"Eshaghi","year":"2026","journal-title":"Nat. Rev. Bioeng."},{"key":"2026090306593993700_cit344","doi-asserted-by":"publisher","first-page":"114218","DOI":"10.1016\/j.jconrel.2025.114218","article-title":"Novel TNF-\u03b1-targeting mRNA therapy for sustained\npsoriasis\ntreatment and relapse prevention by suppressing IL-15-T(RM) signaling","volume":"387","author":"Li","year":"2025","journal-title":"J. Controlled Release"},{"key":"2026090306593993700_cit345","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jconrel.2024.09.020","article-title":"LNP-mRNA vaccine prevents\ntype 1 diabetes in non-obese\ndiabetes mice","volume":"375","author":"Chen","year":"2024","journal-title":"J. Controlled Release"},{"issue":"5","key":"2026090306593993700_cit346","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41577-023-00970-x","article-title":"Therapeutic\ninduction\nof antigen-specific immune tolerance","volume":"24","author":"Kenison","year":"2024","journal-title":"Nat. Rev.\nImmunol."},{"issue":"8","key":"2026090306593993700_cit347","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41551-025-01373-0","article-title":"Generation\nof tolerogenic antigen-presenting cells in vivo via the delivery of\nmRNA encoding PDL1 within lipid nanoparticles","volume":"9","author":"Liu","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"2026090306593993700_cit348","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jconrel.2024.08.018","article-title":"Stealth mRNA\nnanovaccines to control lymph node trafficking","volume":"374","author":"Garci\u0301a-Ferna\u0301ndez","year":"2024","journal-title":"J. Controlled Release"},{"issue":"1","key":"2026090306593993700_cit349","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges,\nProgress,\nand Prospects of Developing Therapies to Treat Autoimmune Diseases","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"key":"2026090306593993700_cit350","doi-asserted-by":"publisher","first-page":"1860221","DOI":"10.3389\/fnano.2026.1860221","article-title":"Nanomaterial-enabled RNA therapeutics:\nbridging delivery barriers\nto clinical translation","volume":"8","author":"Pandey","year":"2026","journal-title":"Front. Nanotechnol."},{"issue":"1","key":"2026090306593993700_cit351","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1186\/s12951-024-02972-w","article-title":"Navigating the intricate\nin-vivo journey of lipid nanoparticles tailored for the targeted delivery\nof RNA therapeutics: a quality-by-design approach","volume":"22","author":"Haghighi","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"13","key":"2026090306593993700_cit352","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1021\/acs.nanolett.1c01353","article-title":"Scalable mRNA and\nsiRNA Lipid Nanoparticle\nProduction Using a Parallelized Microfluidic Device","volume":"21","author":"Shepherd","year":"2021","journal-title":"Nano Lett."},{"issue":"6","key":"2026090306593993700_cit353","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms\nof vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"2026090306593993700_cit354","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies\nin the clinic: Current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Controlled Release"},{"issue":"5","key":"2026090306593993700_cit355","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.fmre.2023.02.022","article-title":"Z., mRNA therapeutics: New vaccination\nand beyond","volume":"3","author":"Wei","year":"2023","journal-title":"Fundam. Res."},{"issue":"7","key":"2026090306593993700_cit356","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/vaccines11071153","article-title":"CMC Strategies and\nAdvanced Technologies\nfor Vaccine Development to Boost Acceleration and Pandemic Preparedness","volume":"11","author":"Castellanos","year":"2023","journal-title":"Vaccines"},{"issue":"2","key":"2026090306593993700_cit357","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ymthe.2020.09.038","article-title":"Personalized\nCancer Vaccines: Clinical Landscape, Challenges, and Opportunities","volume":"29","author":"Shemesh","year":"2021","journal-title":"Mol. Ther."},{"key":"2026090306593993700_cit358","doi-asserted-by":"publisher","first-page":"328","DOI":"10.30574\/gscbps.2024.26.1.0019","article-title":"Quality\nby Design (QbD) in pharmaceutical development: A comprehensive review","volume":"26","author":"Aru","year":"2024","journal-title":"GSC Biol. Pharmaceut. Sci."},{"issue":"11","key":"2026090306593993700_cit359","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"2026090306593993700_cit360","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41467-021-20903-3","article-title":"Murine liver repair via transient\nactivation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed\nnucleoside-modified mRNA","volume":"12","author":"Rizvi","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"2026090306593993700_cit361","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/s41591-018-0199-z","article-title":"Systemic messenger RNA as an etiological\ntreatment for acute intermittent porphyria","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"9","key":"2026090306593993700_cit362","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles\nfor the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"2026090306593993700_cit363","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted\nBBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","author":"Ogawa","year":"2022","journal-title":"J. Controlled Release"},{"issue":"1","key":"2026090306593993700_cit364","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1038\/s41467-024-50093-7","article-title":"Reformulating lipid nanoparticles for organ-targeted\nmRNA accumulation and translation","volume":"15","author":"Su","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"2026090306593993700_cit365","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed\non lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"2026090306593993700_cit366","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tibtech.2018.08.010","article-title":"Non-Viral\nDelivery To Enable Genome\nEditing","volume":"37","author":"Rui","year":"2019","journal-title":"Trends Biotechnol."},{"issue":"3","key":"2026090306593993700_cit367","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.xphs.2021.11.004","article-title":"pH-Dependent Phase\nBehavior and Stability\nof Cationic Lipid-mRNA Nanoparticles","volume":"111","author":"Larson","year":"2022","journal-title":"J. Pharm.\nSci."},{"issue":"3","key":"2026090306593993700_cit368","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing\nthe Cold Reality of mRNA Vaccine Stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"2026090306593993700_cit369","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jconrel.2022.11.022","article-title":"Optimization of\nstorage conditions for lipid nanoparticle-formulated self-replicating\nRNA vaccines","volume":"353","author":"Kim","year":"2023","journal-title":"J. Controlled Release"},{"issue":"2","key":"2026090306593993700_cit370","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.bioactmat.2020.03.001","article-title":"Long-term\nstorage of\nlipid-like nanoparticles for mRNA delivery","volume":"5","author":"Zhao","year":"2020","journal-title":"Bioact. Mater."},{"issue":"3","key":"2026090306593993700_cit371","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41587-023-01774-z","article-title":"A microneedle vaccine printer for thermostable COVID-19\nmRNA vaccines","volume":"42","author":"Vander Straeten","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"2026090306593993700_cit372","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/17425247.2023.2162876","article-title":"Why mRNA-ionizable\nLNPs formulations are so short-lived:\ncauses and way-out","volume":"20","author":"De","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"2026090306593993700_cit373","doi-asserted-by":"publisher","first-page":"126426","DOI":"10.1016\/j.ijpharm.2025.126426","article-title":"Recent advances\nin freeze-drying technologies for mRNA vaccines against infectious\ndiseases","volume":"687","author":"Lou","year":"2026","journal-title":"Int. J. Pharm."},{"issue":"8","key":"2026090306593993700_cit374","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202405618","article-title":"Rational Design of Lipid Nanoparticles\nfor Enhanced mRNA Vaccine Delivery via Machine Learning","volume":"21","author":"Bae","year":"2025","journal-title":"Small"},{"issue":"1","key":"2026090306593993700_cit375","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1021\/acs.accounts.1c00621","article-title":"Machine Learning for Designing Next-Generation\nmRNA Therapeutics","volume":"55","author":"Castillo-Hair","year":"2022","journal-title":"Acc. Chem. Res."},{"issue":"7978","key":"2026090306593993700_cit376","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","article-title":"Algorithm for optimized\nmRNA design improves stability and immunogenicity","volume":"621","author":"Zhang","year":"2023","journal-title":"Nature"},{"issue":"1","key":"2026090306593993700_cit377","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1038\/s41467-024-49508-2","article-title":"Optimizing\n5\u2018UTRs\nfor mRNA-delivered gene editing using deep learning","volume":"15","author":"Castillo-Hair","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"2026090306593993700_cit378","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s41565-025-01975-4","article-title":"Designing lipid nanoparticles using a transformer-based\nneural network","volume":"20","author":"Chan","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"2026090306593993700_cit379","doi-asserted-by":"publisher","first-page":"103265","DOI":"10.1016\/j.mattod.2026.103265","article-title":"Imidazolium lipid-based nanoparticles\nenable effective mRNA delivery and cellular immune response","volume":"95","author":"Lin","year":"2026","journal-title":"Mater. Today"},{"issue":"7","key":"2026090306593993700_cit380","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","article-title":"Accelerating\nionizable lipid discovery for mRNA delivery\nusing machine learning and combinatorial chemistry","volume":"23","author":"Li","year":"2024","journal-title":"Nat. Mater."},{"issue":"11","key":"2026090306593993700_cit381","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/s41587-024-02490-y","article-title":"Artificial intelligence-guided\ndesign of lipid nanoparticles for pulmonary gene therapy","volume":"43","author":"Witten","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"2026090306593993700_cit382","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41551-026-01640-8","article-title":"Artificial\nintelligence-guided design of LNPs for in\nvivo targeted mRNA delivery via analysis of the spatial conformation\nof ionizable lipids","author":"Su","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"2026090306593993700_cit383","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41587-026-03109-0","article-title":"A multiobjective AI\nmodel for LNP engineering enhances tissue-selective mRNA delivery","author":"Zhou","year":"2026","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"2026090306593993700_cit384","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1038\/s41467-024-50619-z","article-title":"AGILE\nplatform: a deep learning powered approach to\naccelerate LNP development for mRNA delivery","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"2026090306593993700_cit385","doi-asserted-by":"publisher","first-page":"10804","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable\nlipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"issue":"9","key":"2026090306593993700_cit386","doi-asserted-by":"publisher","first-page":"2500206","DOI":"10.1002\/smsc.202500206","article-title":"Therapeutic Implications\nof Biomolecular\nCorona on Lipid Nanoparticle-Based Gene Delivery Systems","volume":"5","author":"Greco","year":"2025","journal-title":"Small Sci."},{"issue":"2","key":"2026090306593993700_cit387","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/biochem5020005","article-title":"Advances in Personalized Cancer Vaccine\nDevelopment:\nAI Applications from Neoantigen Discovery to mRNA Formulation","volume":"5","author":"Kong","year":"2025","journal-title":"Biochem"},{"issue":"2","key":"2026090306593993700_cit388","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s13402-026-01199-1","article-title":"Next-generation neoantigen\nmRNA vaccines: Immuno-engineering strategies for precision cancer\nimmunotherapy","volume":"49","author":"Li","year":"2026","journal-title":"Cell. Oncol."},{"issue":"8","key":"2026090306593993700_cit389","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405106122","article-title":"Toward equitable major\nhistocompatibility complex binding predictions","volume":"122","author":"Glynn","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"2026090306593993700_cit390","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001111","article-title":"Antigen\nprocessing and presentation in cancer immunotherapy","volume":"8","author":"Lee","year":"2020","journal-title":"J. Immunother Cancer"},{"key":"2026090306593993700_cit391","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-biodatasci-092820-112713","article-title":"Neoantigen\nControversies","volume":"4","author":"Castro","year":"2021","journal-title":"Annual Rev. Biomed. Data Sci."},{"issue":"3","key":"2026090306593993700_cit392","doi-asserted-by":"publisher","first-page":"189577","DOI":"10.1016\/j.bbcan.2026.189577","article-title":"mRNA-based\ncancer\nvaccines: A new frontier in personalized immunotherapy","volume":"1881","author":"Garg","year":"2026","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"issue":"4","key":"2026090306593993700_cit393","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1001\/jamainternmed.2021.8515","article-title":"Risk of Second\nAllergic Reaction\nto SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis","volume":"182","author":"Chu","year":"2022","journal-title":"JAMA Int. Med."},{"issue":"7","key":"2026090306593993700_cit394","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1056\/NEJMra2035343","article-title":"Maintaining Safety\nwith SARS-CoV-2\nVaccines","volume":"384","author":"Castells","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"2026090306593993700_cit395","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","article-title":"Impact\nof anti-PEG antibodies induced\nby SARS-CoV-2 mRNA vaccines","volume":"23","author":"Ju","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"2026090306593993700_cit396","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement\nactivation-related pseudoallergy: A stress\nreaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol. Immunol."},{"issue":"5","key":"2026090306593993700_cit397","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409572122","article-title":"Rational design and modular synthesis\nof biodegradable ionizable\nlipids via the Passerini reaction for mRNA delivery","volume":"122","author":"Xu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"2026090306593993700_cit398","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated Lipid\nNanoparticle Formulations: Immunological Safety and Efficiency Perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjugate Chem."},{"issue":"4","key":"2026090306593993700_cit399","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/toxics5040029","article-title":"Exposure to Inorganic Nanoparticles:\nRoutes of Entry,\nImmune Response, Biodistribution and In Vitro\/In Vivo Toxicity Evaluation","volume":"5","author":"Matteis","year":"2017","journal-title":"Toxics"},{"issue":"9","key":"2026090306593993700_cit400","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.7150\/thno.131621","article-title":"From bench\nto bedside: the promise and roadblocks of extracellular vesicle therapeutics","volume":"16","author":"Zhang","year":"2026","journal-title":"Theranostics"},{"issue":"45","key":"2026090306593993700_cit401","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404684","article-title":"Discovery of Ketal-Ester Ionizable Lipid Nanoparticle\nwith Reduced\nHepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine Delivery","volume":"11","author":"Lv","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"2026090306593993700_cit402","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12951-025-03681-8","article-title":"Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses\nin a hepatocellular carcinoma model","volume":"23","author":"Wu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"2026090306593993700_cit403","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4049\/immunohorizons.1900029","article-title":"Accelerated\nBlood Clearance\nof Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1\nFollowed by B-2 Lymphocytes to Distinct Antigenic Moieties","volume":"3","author":"Besin","year":"2019","journal-title":"ImmunoHorizons"},{"issue":"10","key":"2026090306593993700_cit404","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/vaccines12101148","article-title":"Recent Advances in Lipid Nanoparticles\nand Their Safety Concerns\nfor mRNA Delivery","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"2026090306593993700_cit405","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40824-023-00425-3","article-title":"mRNA nanodelivery systems: targeting\nstrategies and administration routes","volume":"27","author":"Yuan","year":"2023","journal-title":"Biomater.\nRes."},{"issue":"1","key":"2026090306593993700_cit406","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41541-025-01166-1","article-title":"Trans amplifying mRNA\nvaccine expressing consensus spike elicits broad neutralization of\nSARS CoV 2 variants","volume":"10","author":"Gontu","year":"2025","journal-title":"Npj Vaccines"},{"key":"2026090306593993700_cit407","doi-asserted-by":"publisher","first-page":"ofaf695206","DOI":"10.1093\/ofid\/ofaf695.206","article-title":"mRNA-1608, an mRNA-Based\nTherapeutic Genital Herpes Vaccine Candidate: Interim Safety, Immunogenicity\nand Clinical Endpoint Results from a Phase 1\/2, Randomized, Observer-Blind,\nControlled, Dose-Ranging Trial","volume":"13","author":"Wald","year":"2026","journal-title":"Open Forum Infect.\nDis."},{"issue":"Suppl 1","key":"2026090306593993700_cit408","doi-asserted-by":"publisher","first-page":"ofaf695.077","DOI":"10.1093\/ofid\/ofaf695.077","article-title":"Safety\nand Immunogenicity of BNT166a, an Investigational Quadrivalent mRNA\nMpox Vaccine","volume":"13","author":"Davies","year":"2026","journal-title":"Open Forum Infect. Dis."},{"issue":"Suppl 2","key":"2026090306593993700_cit409","doi-asserted-by":"publisher","first-page":"ofad500.2475","DOI":"10.1093\/ofid\/ofad500.2475","article-title":"2892. Safety and Immunogenicity of mRNA-1647, an mRNA-Based\nCytomegalovirus Vaccine in Healthy Adults: Results of a Phase 2, Randomized,\nObserver-Blind, Placebo-Controlled, Dose-Finding Trial","volume":"10","author":"Panther","year":"2023","journal-title":"Open Forum Infect. Dis."},{"issue":"6","key":"2026090306593993700_cit410","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf292","article-title":"Safety, Tolerability,\nand Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory\nSyncytial Virus Disease Aged 18\u201359 Years","volume":"81","author":"Mayer","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"2026090306593993700_cit411","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/vaccines11121767","article-title":"A Phase I\/II Clinical\nTrial of Intradermal, Controllable Self-Replicating Ribonucleic Acid\nVaccine EXG-5003 against SARS-CoV-2","volume":"27","author":"Koseki","year":"2023","journal-title":"Vaccines"},{"issue":"10","key":"2026090306593993700_cit412","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1128\/CVI.00258-12","article-title":"Phase I safety and\nimmunogenicity\nevaluations of an alphavirus replicon HIV-1 subtype C gag vaccine\nin healthy HIV-1-uninfected adults","volume":"19","author":"Wecker","year":"2012","journal-title":"Clinical\nVaccine Immunol."},{"key":"2026090306593993700_cit413","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-SITC2025.0590","article-title":"590 A first-in-human, phase 1 trial\nof IMA203\nPRAME-directed TCR T-cell therapy with PRAME-encoding mRNA-4203 in\npreviously treated, unresectable or metastatic cutaneous melanoma\nor synovial sarcoma","volume-title":"Journal for ImmunoTherapy\nof Cancer","author":"Smithy","year":"2025"},{"issue":"16_suppl","key":"2026090306593993700_cit414","doi-asserted-by":"publisher","first-page":"TPS9609","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS9609","article-title":"Novel RNA-nanoparticle\nvaccine for the treatment of\nearly melanoma recurrence following adjuvant anti-PD-1 antibody therapy","volume":"42","author":"Doonan","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"2026090306593993700_cit415","doi-asserted-by":"publisher","DOI":"10.1200\/OA-25-00008","article-title":"Three-Year\nUpdate of\na Randomized Phase IIb Study of the Individualized Neoantigen Therapy\nIntismeran Autogene (mRNA-4157, V940) Plus Pembrolizumab Versus Pembrolizumab\nin Resected Melanoma","volume":"3","author":"Carlino","year":"2026","journal-title":"JCO Oncol. Adv."},{"issue":"25","key":"2026090306593993700_cit416","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1200\/JCO-24-02595","article-title":"BO-112 Plus Pembrolizumab for Patients\nWith Anti\u2013PD-1\u2013Resistant Advanced Melanoma: Phase II\nClinical Trial SPOTLIGHT-203","volume":"43","author":"Ma\u0301rquez-Rodas","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"23_suppl","key":"2026090306593993700_cit417","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.2024.42.23_suppl.139","article-title":"Safety, tolerability,\nand immunogenicity of WGc-043 in subjects with EBV-positive cancers:\nResults from an investigator-initiated trial","volume":"42","author":"Peng","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"2026090306593993700_cit418","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1038\/s41591-023-02612-0","article-title":"CLDN6-specific CAR-T cells plus amplifying\nRNA vaccine in relapsed\nor refractory solid tumors: the phase 1 BNT211\u201301 trial","volume":"29","author":"Mackensen","year":"2023","journal-title":"Nat. Med."},{"issue":"13_Supplement","key":"2026090306593993700_cit419","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1158\/1538-7445.AM2021-73","article-title":"Abstract 73: A personal\nneoantigen vaccine NEO-PV-01 in combination with chemotherapy and\npembrolizumab induces broad de novo immune responses in first-line\nnon-squamous NSCLC: Associations with clinical outcomes","volume":"81","author":"Awad","year":"2021","journal-title":"Cancer Res."},{"issue":"9","key":"2026090306593993700_cit420","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41422-025-01142-3","article-title":"Differentiation therapy with hepatocyte nuclear factor\n4\u03b1 for patients with hepatocellular carcinoma","volume":"35","author":"Yin","year":"2025","journal-title":"Cell Res."},{"issue":"15_suppl","key":"2026090306593993700_cit421","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1200\/jco.2008.26.15_suppl.5538","article-title":"Phase I trial of\nIntraperitoneal (IP) administration of a measles virus (MV) derivative\nexpressing the human carcinoembryonic antigen (CEA) in recurrent ovarian\ncancer (OvCa)","volume":"26","author":"Galanis","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"2026090306593993700_cit422","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1172\/JCI42672","article-title":"An alphavirus vector overcomes the presence of neutralizing\nantibodies and elevated numbers of Tregs to induce immune responses\nin humans with advanced cancer","volume":"120","author":"Morse","year":"2010","journal-title":"J. Clinical\nInvest."},{"issue":"2","key":"2026090306593993700_cit423","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001662","article-title":"Long-term survival of\npatients with stage III colon cancer treated\nwith VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector\nmemory T cell to Treg ratio","volume":"8","author":"Crosby","year":"2020","journal-title":"J. Immunother Cancer"},{"issue":"9","key":"2026090306593993700_cit424","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1158\/1078-0432.CCR-18-3102","article-title":"Vaccine-Induced Memory CD8(+) T Cells\nProvide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse\nto Human Translational Study","volume":"25","author":"Crosby","year":"2019","journal-title":"Clinical Cancer\nRes."},{"issue":"8","key":"2026090306593993700_cit425","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41591-022-01937-6","article-title":"Individualized,\nheterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen\nvaccine for advanced metastatic solid tumors: phase 1 trial interim\nresults","volume":"28","author":"Palmer","year":"2022","journal-title":"Nat. Med."},{"issue":"4","key":"2026090306593993700_cit426","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41591-024-02851-9","article-title":"A shared neoantigen\nvaccine combined\nwith immune checkpoint blockade for advanced metastatic solid tumors:\nphase 1 trial interim results","volume":"30","author":"Rappaport","year":"2024","journal-title":"Nat. Med."},{"issue":"12","key":"2026090306593993700_cit427","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1038\/leu.2017.120","article-title":"Phase I trial of\nsystemic administration of Edmonston strain of measles virus genetically\nengineered to express the sodium iodide symporter in patients with\nrecurrent or refractory multiple myeloma","volume":"31","author":"Dispenzieri","year":"2017","journal-title":"Leukemia"}],"container-title":["ACS Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsnano.6c10327","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/34\/23649\/66560143\/acsnano.6c10327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/34\/23649\/66560143\/acsnano.6c10327.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:59:51Z","timestamp":1788433191000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancac3\/article\/20\/34\/23649\/5256281\/Advances-and-Challenges-in-Nanodelivery-Systems"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":427,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1021\/acsnano.6c10327","relation":{},"ISSN":["1936-0851","1936-086X"],"issn-type":[{"value":"1936-0851","type":"print"},{"value":"1936-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}